Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Mar. 31, 2018 | May 15, 2018 | |
Document And Entity Information | ||
Entity Registrant Name | SOCIAL REALITY, Inc. | |
Entity Central Index Key | 1,538,217 | |
Document Type | 10-Q/A | |
Document Period End Date | Mar. 31, 2018 | |
Amendment Flag | true | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Smaller Reporting Company | |
Entity Common Stock, Shares Outstanding | 10,212,738 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2,018 | |
Amendment Description | We are filing this Amendment No. 1 on Form 10-Q/A to amend our Form 10-Q for the period ended March 31, 2018, filed with the Securities and Exchange Commission on May 15, 2018 (the "Form 10 Q"), solely to amend Note 3 to the Financial Statements thereto in order to clarify that on January 1, 2018, we had adopted Accounting Standards Update 2015-14 (Topic 606) and that the adoption had no material impact on our financial statements. |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) | Mar. 31, 2018 | Dec. 31, 2017 | Mar. 31, 2017 | Dec. 31, 2016 |
Current assets: | ||||
Cash and cash equivalents | $ 189,888 | $ 1,017,299 | $ 119,331 | $ 1,048,762 |
Accounts receivable, net | 1,734,058 | 4,348,305 | 6,578,747 | |
Prepaid expenses | 540,753 | 468,336 | 330,432 | |
Other current assets | 300,898 | 300,898 | 6,488 | |
Total current assets | 2,765,597 | 6,134,838 | 7,034,998 | |
Property and equipment, net of accumulated depreciation | 165,898 | 154,546 | 58,079 | |
Goodwill | 15,644,957 | 15,644,957 | 15,644,957 | |
Intangibles - net | 1,708,349 | 1,642,760 | 924,011 | |
Other assets | 32,043 | 28,598 | 34,659 | |
Total assets | 20,316,844 | 23,605,699 | 23,696,704 | |
Current liabilities: | ||||
Accounts payable and accrued expenses | 4,682,794 | 5,010,815 | 12,960,933 | |
Total current liabilities | 4,682,794 | 5,010,815 | 14,460,933 | |
Secured convertible debentures, net | 2,043,804 | 1,711,146 | ||
Total liabilities | 6,726,598 | 6,721,961 | ||
Commitments and contingencies (Note 13) | ||||
Stockholders' equity | ||||
Preferred stock, authorized 50,000,000 shares, $0.001 par value, no shares issued or outstanding at March 31, 2018 and December 31, 2017, respectively | ||||
Common stock to be issued | 10,000 | 879,500 | ||
Additional paid in capital | 38,328,359 | 37,143,033 | 24,500,328 | |
Accumulated deficit | (24,758,326) | (21,148,706) | (15,272,582) | |
Total stockholders' equity | 13,590,246 | 16,883,738 | 9,235,771 | |
Total liabilities and stockholders' equity | 20,316,844 | 23,605,699 | 23,696,704 | |
Common Class A [Member] | ||||
Stockholders' equity | ||||
Common stock | 10,213 | 9,911 | 8,025 | |
Common Class B [Member] | ||||
Stockholders' equity | ||||
Common stock |
CONDENSED CONSOLIDATED BALANCE3
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Mar. 31, 2018 | Dec. 31, 2017 | Mar. 31, 2017 | Dec. 31, 2016 |
Preferred Stock, shares authorized | 50,000,000 | 50,000,000 | 50,000,000 | 50,000,000 |
Preferred Stock, par value per share | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 |
Preferred Stock, shares issued | 0 | 0 | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 | 0 | 0 |
Common Class A [Member] | ||||
Common Stock, shares authorized | 250,000,000 | 250,000,000 | 50,000,000 | 50,000,000 |
Common Stock, par value per share | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 |
Common Stock, shares issued | 10,212,738 | 9,910,565 | 8,025,017 | 6,951,077 |
Common Stock, shares outstanding | 10,212,738 | 9,910,565 | 8,025,017 | 6,951,077 |
Common Class B [Member] | ||||
Common Stock, shares authorized | 9,000,000 | 9,000,000 | 9,000,000 | 9,000,000 |
Common Stock, par value per share | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 |
Common Stock, shares issued | 0 | 0 | 0 | 0 |
Common Stock, shares outstanding | 0 | 0 | 0 | 0 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
Income Statement [Abstract] | ||
Revenues | $ 2,110,850 | $ 5,326,163 |
Cost of revenue | 818,105 | 3,279,120 |
Gross profit | 1,292,745 | 2,047,043 |
Operating expense | ||
General, selling and administrative expense | 4,130,258 | 4,409,807 |
Write-off of non-compete agreement | 468,751 | |
Restructuring costs | 377,961 | |
Total operating expense, net | 4,130,258 | 5,256,519 |
Loss from operations | (2,837,513) | (3,209,476) |
Other income (expense) | ||
Interest income (expense) | (434,785) | (133,306) |
Amortization of debt issuance costs | (332,658) | (578,140) |
Total interest expense | (767,443) | (711,446) |
Exchange Gain or Loss | (4,664) | |
Total other income (expense) | (772,107) | (711,446) |
Loss before provision for income taxes | (3,609,620) | (3,920,922) |
Provision for income taxes | ||
Net loss | $ (3,609,620) | $ (3,920,922) |
Net (loss) income per share, basic and diluted | $ (0.36) | $ (0.50) |
Weighted average shares outstanding, basic and diluted | 10,037,905 | 7,844,127 |
CONDENSED CONSOLIDATED STATEME5
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
Cash flows from operating activities | ||
Net income (loss) | $ (3,609,620) | $ (3,920,922) |
Adjustments to reconcile net loss to net cash used by operating activities: | ||
Stock based compensation | 166,130 | 512,442 |
Amortization of debt issue costs | 93,639 | 578,140 |
Amortization of debt discount | 239,018 | |
Write-off of non-compete agreement | 468,751 | |
Provision for bad debts | (425) | (8,277) |
Depreciation expense | 9,441 | 3,234 |
Amortization of intangibles | 166,185 | 107,720 |
Changes in operating assets and liabilities: | ||
Accounts receivable | 2,614,671 | 1,840,549 |
Prepaid expenses | (72,416) | 2,071 |
Other assets | (3,445) | |
Accounts payable and accrued expenses | (178,022) | (195,150) |
Cash (used) provided by operating activities | (574,844) | (611,442) |
Cash flows from investing activities: | ||
Purchase of equipment | (20,793) | (5,821) |
Development of software | (231,774) | (135,241) |
Cash used in investing activities | (252,567) | (141,062) |
Cash flows from financing activities: | ||
Proceeds from the issuance of common stock, net | 3,820,001 | |
Repayments of note payable and PIK interest | (3,996,928) | |
Net cash provided by financing activities | (176,927) | |
Net decrease in cash and cash equivalents | (827,411) | (929,431) |
Cash and cash equivalents, beginning of period | 1,017,299 | 1,048,762 |
Cash and cash equivalents, end of period | 189,888 | 119,331 |
Supplemental Schedule of Cash Flow Information: | ||
Cash paid for interest | 340,684 | 550,695 |
Cash paid for taxes | ||
Supplemental Schedule of noncash financing activities: | ||
Common stock issued for preferred stock conversion and vesting grants | 52 | |
Vesting of common stock award | 150,000 | |
Put liability on issuance of warrants | 2,500,000 | |
Issuance of common stock to be issued | $ 869,500 | $ 100 |
DESCRIPTION OF BUSINESS AND BAS
DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION | 3 Months Ended |
Mar. 31, 2018 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION | NOTE 1 DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION Description of Business Social Reality, Inc. ("Social Reality" or SRAX) is a Delaware corporation formed on August 2, 2011. These unaudited condensed consolidated financial statements include the consolidated results of Social Reality and its wholly owned subsidiary, Big Token, Inc. (BigToken) (collectively referred to as we, us, our or the Company). We are headquartered in Los Angeles, California. We are a digital marketing and data management company that delivers our customers the ability to reach and engage with their target audiences We derive our revenue from: · sales of digital advertising campaigns to advertising agencies and brands; · sales of media inventory owned by our publishing partners through real-time bidding, or RTB, exchanges; · sales and licensing of our SRAX Social · creation of custom platforms for buying media on SRAX Basis of Presentation The accompanying unaudited condensed consolidated financial statements and notes thereto are unaudited. The unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and note disclosures normally included in the Companys annual financial statements have been condensed or omitted. The December 31, 2017 condensed balance sheet data was derived from financial statements, but does not include all disclosures required by GAAP. These interim financial statements, in the opinion of management, reflect all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim three month period ended March 31, 2018 and 2017. The results for the three months ended March 31, 2018 are not necessarily indicative of the results to be expected for the year ending December 31, 2018 or for any future period. These unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto for the year ended December 31, 2017, included in the Company's annual report on Form 10-K filed with the SEC on April 2, 2018, as amended on Form 10-K/A (Amendment No. 1) as filed with the SEC on April 27, 2018. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
Mar. 31, 2018 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Uses and Sources of Liquidity Our primary need for liquidity is to fund working capital requirements of our business, development of internally used software and for general corporate purposes, including debt repayment. Our general, selling and administrative expenses decreased from $4,409,807 for the three months ended March 31, 2017 to $4,130,258 for the three months ended March 31, 2018. We incurred a loss of $3,609,620 for the three months ended March 31, 2018 compared to a net loss of $3,920,922 for the three months ended March 31, 2017. At March 31, 2018, we had an accumulated deficit of $24,758,326. As of March 31, 2018, we had $189,888 in cash and cash equivalents and a deficit in working capital of $1,917,197 as compared to $1,017,299 in cash and cash equivalents and a surplus in working capital of $1,124,023 at December 31, 2017. We continue to experience a period of limited liquidity resulting from the complete repayment of senior secured notes associated with a financing agreement previously held by Victory Park Management, LLC and the repurchase of the Series B Warrants, both in April 2017. Additionally, in October 2017 we satisfied all amounts outstanding to Victory Park Management, LLC related to its put right for the repurchase of the Financing Warrant (as defined in Note 8), amounting to $1,500,000 plus accrued interest. See Note 8 for a further discussion of this obligation. We acknowledge that we continue to face a challenging competitive environment and while we continue to focus on our overall profitability, including managing expenses, we reported losses and have historically required funding of cash used in operating and investing activities with cash provided by financing activities. We expect that the actions initiated in the second half of 2017 will enhance our liquidity and financial flexibility in the first half of 2018. In late 2017, we announced several new revenue initiatives that could provide additional revenue growth opportunities anticipated to begin in the second half of 2018. In late 2017, we also announced that we had engaged outside advisors to evaluate potential strategic opportunities for our SRAXmd product group that could ultimately result in a sale of that product line, potentially adding additional liquidity for the Company. We believe that the actions discussed above are probable of occurring and will enable us to satisfy our estimated liquidity needs 12 months from the issuance of the financial statements. However, we cannot predict, with certainty, the outcome of our actions to generate liquidity or whether such actions would generate the expected liquidity as currently planned. If we continue to experience operating losses, and we are not able to generate additional liquidity through the mechanisms described above or through some combination of other actions, while not expected, we may not be able to access additional funds and we might need to secure additional sources of funds, which may or may not be available to us under terms and conditions that are favorable to our success. Additionally, a failure to generate additional liquidity could negatively impact our access to services that are important to the operation of our business. Effect of Reverse Stock Split on Presentation In September 2016, the Company completed a 1 for 5 reverse stock split of our Class A common stock. These unaudited condensed consolidated financial statements give retroactive effect to the reverse stock split for all periods presented, unless otherwise specified. Effect of ASU No. 2017-11 on Previously Issued Financial Statements In July 2017, the Financial Accounting Standards Board (FASB) issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815): Part 1 Accounting for Certain Financial Instruments with Down Round Features and Part 2 Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with Scope Exception Topic 480, Distinguishing Liabilities from Equity, FASB Accounting Standards Codification The Company early adopted the guidance under ASU 2017-11 for the year end December 31, 2017, and recognized warrants issued in 2017 with a down round feature as equity. Adjustments to the Companys previously issued financial statements were required for the retrospective application of this standard. As such the financial statements for three month period ended March 31, 2017 have been reclassified to reflect the adoption of ASU 2017-11. March 31, 2017 March 31, 2017 As Reported Adjustments As Adjusted Assets Current assets: Cash and cash equivalents 119,331 119,331 Accounts receivable, net 6,578,747 6,578,747 Prepaid expenses 330,432 330,432 Other current assets 6,488 6,488 Total current assets 7,034,998 7,034,998 Property and equipment, net 58,079 58,079 Goodwill 15,644,957 15,644,957 Intangibles assets, net 924,011 924,011 Other assets 34,659 34,659 Total assets 23,696,704 23,696,704 Liabilities and Stockholders' Equity Current liabilities: Accounts payable and accrued expenses 12,960,933 12,960,933 Note payable, net of unamortized costs Put warrant liability 1,143,781 (1,143,781 ) Put liability 1,500,000 1,500,000 Total current liabilities 15,604,714 (1,143,781 ) 14,460,933 Commitments and contingencies (Note 11) Stockholders' equity: Preferred stock, authorized 50,000,000 shares, $0.001 par value, no shares issued or outstanding at March 31, 2017 and December 31, 2016, respectively Class A common stock, authorized 50,000,000 shares, $0.001 par value, 8,025,017 and 6,951,077 shares issued and outstanding at March 31, 2017 and December 31, 2016, respectively 8,025 8,025 Class B common stock, authorized 9,000,000 shares, $0.001 par value, no shares issued or outstanding at March 31, 2017 and December 31, 2016, respectively Common stock to be issued Additional paid in capital 24,500,328 - 24,500,328 Accumulated deficit (16,416,363 ) 1,143,781 (15,272,582 ) Total stockholders' equity 8,091,990 1,143,781 9,235,771 Total liabilities and stockholders' equity 23,696,704 - 23,696,704 Three Month Period ended Three Month Period ended March 31, 2017 March 31, 2017 As Reported Adjustments As Adjusted Revenue 5,326,163 5,326,163 Cost of revenue 3,279,120 3,279,120 Gross profit 2,047,043 2,047,043 Operating expense General, selling and administrative expense 4,409,807 4,409,807 Write-off of non-compete agreement 468,751 468,751 Restructuring costs 377,961 377,961 Total operating expense, net 5,256,519 5,256,519 Loss from operations (3,209,476 ) (3,209,476 ) Other income (expense): Interest expense: Interest expense (133,306 ) (133,306 ) Amortization of debt issuance costs (578,140 ) (578,140 ) Total interest expense (711,446 ) (711,446 ) Accretion of put warrants 1,894,563 (1,894,563 ) Total other income (expense) 1,183,117 (1,894,563 ) (711,446 ) Loss before provision for income taxes (2,026,359 ) (1,894,563 ) (3,920,922 ) Provision for income taxes Net loss (2,026,359 ) (1,894,563 ) (3,920,922 ) Net loss per share, basic and diluted (0.26 ) (0.24 ) (0.50 ) Weighted average shares outstanding, basic and diluted 7,844,127 7,844,127 Three Month Period Ended Three Month Period ended March 31, 2017 March 31, 2017 As Reported Adjustments As Adjusted Cash flows from operating activities Net loss (2,026,359 ) (1,894,563 ) (3,920,922 ) Adjustments to reconcile net loss to net cash used in operating activities: Stock based compensation 512,442 512,442 Amortization of debt issuance costs 578,140 578,140 Accretion of put warrants (1,894,563 ) 1,894,563 Write-off of non-compete agreement 468,751 468,751 Provision for bad debts (8,277 ) (8,277 ) Depreciation expense 3,234 3,234 Amortization of intangibles 107,720 107,720 Changes in operating assets and liabilities: Accounts receivable 1,840,549 1,840,549 Prepaid expenses 2,071 2,071 Other current assets Accounts payable and accrued expenses (195,150 ) (195,150 ) Unearned revenue Net cash used in operating activities (611,442 ) (611,442 ) Cash flows from investing activities Purchase of equipment (5,821 ) (5,821 ) Development of software (135,241 ) (135,241 ) Net cash used in investing activities (141,062 ) (141,062 ) Cash flows from financing activities Proceeds from the issuance of common stock 3,820,001 3,820,001 Proceeds from notes payable Repayments of note payable and PIK interest (3,996,928 ) (3,996,928 ) Net cash (used in) provided by financing activities (176,927 ) (176,927 ) Net (decrease) increase in cash and cash equivalents (929,431 ) (929,431 ) Cash and cash equivalents, beginning of period 1,048,762 1,048,762 Cash and cash equivalents, end of period 119,331 119,331 Supplemental schedule of cash flow information Cash paid for interest 550,695 550,695 Cash paid for taxes Principles of Consolidation The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All material intercompany transactions and balances have been eliminated in consolidation. Use of Estimates The unaudited condensed consolidated financial statements have been prepared in conformity with GAAP and requires management of the Company to make estimates and assumptions in the preparation of these unaudited condensed consolidated financial statements that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting periods. Actual results could differ from these estimates and assumptions. The most significant areas that require management judgment and which are susceptible to possible change in the near term include the Company's revenue recognition, allowance for doubtful accounts and sales credits, stock-based compensation, income taxes, goodwill, other intangible assets, put rights and valuation of liabilities. Cash and Cash Equivalents The Company considers all short-term highly liquid investments with a remaining maturity at the date of purchase of three months or less to be cash equivalents. Revenue Recognition The Company recognizes revenue when the following criteria have been met: persuasive evidence of an arrangement exists; no significant Company obligations remain; collection of the related receivable is reasonably assured; and the fees are fixed or determinable. The Company acts as a principal in revenue transactions as the Company is the primary obligor in the transactions. As such, revenue is recognized on a gross basis, and media and publisher expenses that are directly related to a revenue-generating event are recorded as a component of cost of revenue. Cost of Revenue Cost of revenue consists of payments to media providers and website publishers that are directly related to either a revenue-generating event or project and application design costs. The Company becomes obligated to make payments related to media providers and website publishers in the period the advertising impressions, click-through, actions or lead-based information are delivered or occur. Such expenses are classified as cost of revenue in the corresponding period in which the revenue is recognized in the accompanying unaudited condensed consolidated statements of operations. Accounts Receivable Credit is extended to customers based on an evaluation of their financial condition and other factors. Management periodically assesses the Company's accounts receivable and, if necessary, establishes an allowance for estimated uncollectible amounts. Accounts determined to be uncollectible are charged to operations when that determination is made. The Company does not require collateral. Allowance for doubtful accounts was $59,278 and $59,703 at March 31, 2018 and December 31, 2017, respectively. Concentration of Credit Risk, Significant Customers and Supplier Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and accounts receivable. Cash and cash equivalents are deposited with financial institutions within the United States. The Company has not experienced any loss on these accounts. The balances are maintained in demand accounts to minimize risk. At March 31, 2018, three customers accounted for more than 10% of the accounts receivable balance for a total of 57.4%. At December 31, 2017, four customers accounted for more than 10% of the accounts receivable balance for a total of 59.5%. For the three months ended March 31, 2018, two customers accounted for more than 10% of total revenue for a total of 44.9%. For the three months ended March 31, 2017, one customer accounted for 25.9% of total revenue. Fair Value of Financial Instruments The accounting standard for fair value measurements provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Companys principal or, in absence of a principal, most advantageous market for the specific asset or liability. The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows: ● Level 1 — ● Level 2 — ● Level 3 — The Company's financial instruments, including cash and cash equivalents, net accounts receivable, accounts payable and accrued expenses, are carried at historical cost. At March 31, 2018 and December 31, 2017, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments. Derivative instruments are carried at fair value, generally estimated using the Black Scholes Merton model. Property and equipment Property and equipment is stated at cost less accumulated depreciation. Depreciation is provided on the straight-line basis over the estimated useful lives of the assets of three to seven years. Expenditures for repair and maintenance which do not materially extend the useful lives of property and equipment are charged to operations. When property or equipment is sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the respective accounts with the resulting gain or loss reflected in operations. Management periodically reviews the carrying value of its property and equipment for impairment. Intangible assets Intangible assets consist of intellectual property, a non-complete agreement, and internally developed software and are stated at cost less accumulated amortization. Amortization is provided for on the straight-line basis over the estimated useful lives of the assets of three to six years. During 2016, the Company began capitalizing the costs of developing internal-use computer software, including directly related payroll costs. The Company capitalizes costs incurred during the application development stage of internal-use software and amortize these costs over the estimated useful life. Upgrades and enhancements are capitalized if they result in added functionality which enable the software to perform tasks it was previously incapable of performing. Software maintenance, training, data conversion, and business process reengineering costs are expensed in the period in which they are incurred. The Company capitalizes the costs of developing internal-use computer software, including directly related payroll costs. The Company amortizes costs associated with its internally developed software over periods up to three years, beginning when the software is ready for its intended use. Business Combinations For all business combinations (whether partial, full or step acquisitions), the Company records 100% of all assets and liabilities of the acquired business, including goodwill, generally at their fair values; contingent consideration, if any, is recognized at its fair value on the acquisition date and, for certain arrangements, changes in fair value are recognized in earnings until settlement and acquisition-related transaction and restructuring costs are expensed rather than treated as part of the cost of the acquisition. Goodwill and annual impairment testing period Goodwill is comprised of the purchase price of business combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill is not amortized. The Company assesses goodwill for impairment at least annually, or when events or changes in the business environment indicate the carrying value may not be fully recoverable. The Company also has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads the Company to determine that it is more likely than not (that is, a likelihood of more than 50%) that goodwill is impaired. If the Company chooses to first assess qualitative factors and it is determined that it is not more likely than not goodwill is impaired, the Company is not required to take further action to test for impairment. The Company also has the option to bypass the qualitative assessment and perform only the quantitative impairment test, which the Company may choose to do in some periods but not in others. The Company performs its annual impairment review as of December 31 st The Company had historically performed its annual goodwill and impairment assessment on September 30 th st When evaluating the potential impairment of goodwill, management first assess a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company's products and services, regulatory and political developments, entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company's reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we then proceed to a two-step impairment testing methodology using the income approach (discounted cash flow method). In the first step of the two-step testing methodology, we compare the carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows. If the carrying value of a reporting unit exceeds its fair value, we then complete the second step of the impairment test to determine the amount of impairment to be recognized. In the second step, we estimate an implied fair value of the reporting unit's goodwill by allocating the fair value of the reporting unit to 100% of the assets and liabilities other than goodwill (including any unrecognized intangible assets). If the carrying value of a reporting unit's goodwill exceeds its implied fair value, the Company records an impairment loss equal to the difference in that period. When required, we arrive at our estimates of fair value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or estimates for future cash flows could produce different results. The impairment charge represents the excess of the carrying amount of the goodwill recorded in the acquisition over the implied fair value of the goodwill. The implied fair value of the goodwill is the residual fair value based on an income approach that utilized a discounted cash flow model based on revenue and profit forecasts. The Company performed its annual impairment test and no impairment of goodwill has been recorded during the three months ended March 31, 2018 or 2017, respectively. Long-lived Assets Management evaluates the recoverability of the Company's identifiable intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists. Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable include, but are not limited to: significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; a significant decline in the Company's stock price for a sustained period of time; and changes in the Company's business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets. If impairment is indicated based on a comparison of the assets' carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. No impairments have been recorded regarding its identifiable intangible assets or other long-lived assets during the three months ended March 31, 2018 or 2017, respectively. Derivatives The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic No. 480, Distinguishing Liabilities From Equity Derivatives and Hedging Loss Per Share We use Accounting Standards Codification (ASC) 260, " Earnings Per Share There were 5,053,258 common share equivalents at March 31, 2018 and 3,619,331 common share equivalents at March 31, 2017. For the three months ended March 31, 2018 and 2017, respectively, these potential shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would reduce net loss per share. Income Taxes We utilize ASC 740 Income Taxes The Company recognizes the impact of a tax position in the consolidated financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense. Stock-Based Compensation We account for our stock based compensation under ASC 718 " Compensation Stock Compensation We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods. Common stock awards The Company grants common stock awards to non-employees in exchange for services provided. The Company measures the fair value of these awards using the fair value of the services provided or the fair value of the awards granted, whichever is more reliably measurable. The fair value measurement date of these awards is generally the date the performance of services is complete. The fair value of the awards is recognized on a straight-line basis as services are rendered. The share-based payments related to common stock awards for the settlement of services provided by non-employees is recorded on the consolidated statement of comprehensive loss in the same manner and charged to the same account as if such settlements had been made in cash. Warrants In connection with certain financing, consulting and collaboration arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are standalone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded at fair value as a reduction in additional paid-in capital of the common stock issued. All other warrants are recorded at fair value as expense over the requisite service period or at the date of issuance, if there is not a service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 11, Stockholders Equity . Business Segments The Company uses the "management approach" to identify its reportable segments. The management approach designates the internal organization used by management for making operating decisions and assessing performance as the basis for identifying the Company's reportable segments. Using the management approach, the Company determined that it has one operating segment due to business similarities and similar economic characteristics. |
IMPACT OF RECENTLY ISSUED ACCOU
IMPACT OF RECENTLY ISSUED ACCOUNTING STANDARDS | 3 Months Ended |
Mar. 31, 2018 | |
Accounting Policies [Abstract] | |
IMPACT OF RECENTLY ISSUED ACCOUNTING STANDARDS | NOTE 3 IMPACT OF RECENTLY ISSUED ACCOUNTING STANDARDS Adoption of New Accounting Standards For a discussion of recent accounting pronouncements, please refer to Recently Issued Accounting Standards as contained in Note 1 in the December 31, 2017 audited consolidated financial statements included in the Companys annual report on Form 10-K filed with the SEC on April 2, 2018. In May 2014, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2014-09 “Revenue from Contracts with Customers” to supersede previous revenue recognition guidance under current U.S. GAAP. The guidance presents a single five-step model for comprehensive revenue recognition that requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Two options are available for implementation of the standard which is either the retrospective approach or cumulative effect adjustment approach. The guidance becomes effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, with early adoption permitted. The Company adopted ASU 2014-09 using the modified retrospective transition method in the first quarter of 2018 and such adoption did not have a material impact on the condensed consolidated financial statements. The Company has established it only earns revenue from contracts with customers for advertising services. Therefore, the disclosure requirement to disaggregate revenue information is not material to the Company’s current business model. These revenue contracts are generally short term in nature, and no more than one year maximum. The transaction price per contract is derived on prenegotiated cost per thousand (“CPM”) impression basis. The Company recognizes its revenue from these contracts when it delivers the quantity of advertising impressions for the current period as stipulated in the customer contract. Once advertising impressions have been delivered, performance under these contracts is satisfied, and there is no ongoing obligation for the Company with regard to returns or warranty. In September 2017, the FASB issued ASU 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842). The effective date for ASU 2017-13 is for fiscal years beginning after December 31, 2017. The adoption of this ASU did not have a material impact to our consolidated financial statements. Accounting Standards Issued But Not Yet Effective In July 2017, the Financial Accounting Standards Board (FASB) issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815): Part 1 Accounting for Certain Financial Instruments with Down Round Features and Part 2 Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with Scope Exception Topic 480, Distinguishing Liabilities from Equity, FASB Accounting Standards Codification In January 2017, the FASB issued ASU No. 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment In October 2016, the FASB issued ASU No. 2016-16, Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory In August 2016, the FASB issued ASU No. 2016-15, Classification of Certain Cash Receipts and Cash Payments In connection with its financial instruments project, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments Financial Instruments - Overall: Recognition and Measurement of Financial Assets and Financial Liabilities · ASU No. 2016-13 introduces a new impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, entities will be required to use a forward-looking expected loss model that will replace the current incurred loss model and generally will result in earlier recognition of allowances for losses. The guidance will be effective for the first interim period of our 2021 fiscal year, with early adoption in fiscal year 2020 permitted. · ASU No. 2016-01 addresses certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. Among other provisions, the new guidance requires the fair value measurement of investments in certain equity securities. For investments without readily determinable fair values, entities have the option to either measure these investments at fair value or at cost adjusted for changes in observable prices minus impairment. All changes in measurement will be recognized in net income. The guidance will be effective for the first interim period of our 2019 fiscal year. Early adoption is not permitted, except for certain provisions relating to financial liabilities. In March 2016, the FASB issued ASU No. 2016-08, Revenue from Contracts with Customer (Topic 606): Principal versus Agent Considerations - Reporting Revenue Gross versus Net In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) In May 2014, the FASB issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers (Topic 606), to clarify the principles used to recognize revenue for all entities. The FASB deferred implementation of this guidance by one year with the issuance of Accounting Standards Update 2015-14. The Company adopted this guidance on January 1, 2018 using the modified retrospective method with no impact on its consolidated financial statements for the two years ending December 31, 2017. The cumulative effect of initially applying the new guidance had no impact on the opening balance of retained earnings as of January 1, 2018 and the Company does not expect this guidance will have a material impact on its consolidated financial statements in future periods. Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed consolidated financial statements. |
ACQUISITIONS
ACQUISITIONS | 3 Months Ended |
Mar. 31, 2018 | |
Business Combinations [Abstract] | |
ACQUISITIONS | NOTE 4 ACQUISITIONS On October 30, 2014, we acquired 100% of the capital stock of Steel Media from Richard Steel pursuant to the terms and conditions of a stock purchase agreement, dated October 30, 2014, by and among the Company, Steel Media and Mr. Steel (the "Stock Purchase Agreement"). The Company did not engage in any acquisition activity during the three months ended March 31, 2018 or during the twelve months ended December 31, 2017. On October 17, 2017, the Company issued a press release announcing it has engaged financial advisors to explore strategic alternatives for the company's SRAXmd business. |
PROPERTY AND EQUIPMENT, NET
PROPERTY AND EQUIPMENT, NET | 3 Months Ended |
Mar. 31, 2018 | |
Property, Plant and Equipment [Abstract] | |
PROPERTY AND EQUIPMENT, NET | NOTE 5 PROPERTY AND EQUIPMENT, NET Property and equipment consists of the following at March 31, 2018 and December 31, 2017: March 31, 2018 December 31, 2017 Office equipment $ 272,207 $ 251,415 Accumulated depreciation (106,309 ) (96,869 ) Property and equipment, net $ 165,898 $ 154,546 Depreciation expense for the three months ended March 31, 2018 and 2017 was $9,441 and $3,234, respectively. |
INTANGIBLE ASSETS, NET
INTANGIBLE ASSETS, NET | 3 Months Ended |
Mar. 31, 2018 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
INTANGIBLE ASSETS, NET | NOTE 6 INTANGIBLE ASSETS, NET Intangible assets consist of the following: March 31, 2018 December 31, 2017 Non-compete agreement $ 1,250,000 $ 1,250,000 Intellectual property 756,000 756,000 Acquired software - Leapfrog 617,069 617,069 Internally developed software 985,914 754,140 3,608,983 3,377,209 Accumulated amortization (1,900,634 ) (1,734,449 ) Carrying value $ 1,708,349 $ 1,642,760 During the three months ended March 31, 2018, the Company capitalized $231,774 of costs associated with the development of internal-use software, including directly related payroll costs. On August 17, 2017, the Company acquired software from Leapfrog Media Trading in exchange for 200,000 shares of Class A common stock and 350,000 warrants with a term of five years and an exercise price of $3.00. This software is currently being integrated into our platform and we estimate launching on July 1, 2018. No other assets, customers, employees, intangibles or business operations were acquired in this transaction. In connection with a separation and release agreement with Mr. Steel, the Company agreed to reduce the remaining period of the non-compete agreement with Mr. Steel, which was entered into as a result of the acquisition of Steel Media, to a period of eighteen months from the date of his separation from the Company. Accordingly, the Company wrote off $468,750 in value of the non-compete agreement during 2017. Amortization expense was $37,800 for intellectual property, $52,083 for the non-compete agreement and $76,301 for the internally developed software for the three months ended March 31, 2018. Amortization expense was $37,800 for intellectual property, $52,083 for the non-compete agreement, and $17,837 for the internally developed software for the three months ended March 31, 2017. The estimated future amortization expense for the remainder of 2018 and the years ended December 31 thereafter, are as follows: Remainder of 2018 $ 514,592 2019 662,094 2020 205,690 2021 325,973 $ 1,708,349 |
ACCOUNTS PAYABLE AND ACCRUED EX
ACCOUNTS PAYABLE AND ACCRUED EXPENSES | 3 Months Ended |
Mar. 31, 2018 | |
Accounts Payable and Accrued Liabilities [Abstract] | |
ACCOUNTS PAYABLE AND ACCRUED EXPENSES | NOTE 7 ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts payable and accrued expenses are comprised of the following: March 31, 2018 December 31, 2017 Accounts payable, trade $ 3,145,279 $ 2,858,871 Accrued expenses 1,440,440 1,800,621 Accrued compensation 94,128 256,164 Accrued commissions 2,947 95,159 Total $ 4,682,794 $ 5,010,815 |
NOTES PAYABLE
NOTES PAYABLE | 3 Months Ended |
Mar. 31, 2018 | |
Notes Payable [Abstract] | |
NOTES PAYABLE | NOTE 8 NOTES PAYABLE Financing Agreement with Victory Park Management, LLC as agent for the lenders On October 30, 2014 (the "Financing Agreement Closing Date"), the Company entered a financing agreement (the "Financing Agreement") with Victory Park Management, LLC, as administrative agent and collateral agent for the lenders and holders of notes and warrants issued thereunder (the "Agent"). The initial and subsequent notes issued (the Financing Notes) bore interest at a rate per annum equal to the sum of (1) cash interest at a rate of 10% per annum and (2) payment-in-kind (PIK) interest at a rate of 4% per annum for the period commencing on the Financing Agreement Closing Date and extending through the last day of the calendar month during which the Company's financial statements for December 31, 2014 are delivered, and which PIK interest rate thereafter from time to time may be adjusted based on the ratio of the Company's consolidated indebtedness to its earnings before interest, taxes, depreciation and amortization. If the Company achieved a reduction in the leverage ratio as described in the Financing Agreement, the PIK interest rate declined on a sliding scale from 4% to 2%. The Financing Notes issued under the Financing Agreement were scheduled to mature on October 30, 2017. During 2017, we completely repaid the Financing Notes and made principal and PIK interest repayments in the amount of $3,996,928. Notes payable consisted of the following at December 31, 2017: We incurred a total of $3,164,352 of costs related to the Financing Agreement. These costs were amortized to interest expense over the life of the debt. During the three months ended March 31, 2018 and 2017, $0 and $578,140, respectively, of debt issuance costs were amortized as interest expense. As of March 31, 2018, all deferred debt issuance costs have been completely amortized. During the three months ended March 31, 2018 and 2017, $0 and $0, respectively, were recorded as PIK interest expense. Pursuant to the Financing Agreement, the Company issued to the lender a five-year warrant to purchase 580,000 shares of its Class A common stock at an exercise price of $5.00 per share (the "Financing Warrant"). The warrant holder was not, however, permitted to exercise the Financing Warrant for shares of Class A common stock that would cause such holder to beneficially own shares of Class A common stock that exceeds 4.99% of the Company's outstanding shares of Class A common stock following such exercise. Pursuant to the Financing Warrant, the warrant holder had the right, at any time after the earlier of April 30, 2016 and the maturity date of the Financing Notes issued, but prior to October 30, 2019, to exercise its put right under the terms of the Financing Warrant, pursuant to which the warrant holder may sell to the Company, and the Company will purchase from the warrant holder, all or any portion of the Financing Warrant that had not been previously exercised. In connection with any exercise of this put right, the purchase price was to equal to an amount based upon the percentage of the Financing Warrant for which the put right is being exercised, multiplied by the lesser of (a) 50% of the total consolidated revenue for the Company for the trailing 12-month period ending with the Company's then-most recently completed fiscal quarter, and (b) $1,500,000. In May 2017, the Company was notified by the warrant holder that it was exercising its put right. We had a period of 45 days from the date of notice to repay the right or negotiate a settlement. If the right remained unpaid after the 45-day period, interest would accrue on the unpaid balance at a rate of 14% per annum. On October 27, 2017, the Company paid the warrant holder $1,567,612, which was comprised of the $1,500,000 warrant value and an additional $67,612 of accrued interest. As contemplated under the Financing Agreement, the Company also entered a registration rights agreement on the Financing Agreement Closing Date (the "Financing Registration Rights Agreement") with the holder of the Financing Warrant, pursuant to which the Company granted to such holder certain "piggyback" rights to register the shares of the Company's Class A common stock issuable upon exercise of the Financing Warrant. Specifically, the holder of the Financing Warrant had the right, subject to certain allocation provisions set forth in the Financing Registration Rights Agreement, to include the shares underlying the Financing Warrant in registration statements for offerings by the Company of its Class A common stock, as well as offerings of the Company's Class A common stock held by third parties. The shares underlying the Financing Warrant were initially included in a Post-Effective Amendment No. 1 to the registration statement on Form S-1 that was declared effective by the SEC in March 2016. Financing and Security Agreement with FastPay In September 2016, the Company executed a Financing and Security Agreement, as amended (collectively, the "FastPay Agreement"). with FastPay Partners, LLC to create an accounts receivable-based credit facility. The FastPay Agreement was further amended in April 2018. Under the April 2018 amended terms of the FastPay Agreement, FastPay may, at its sole discretion, purchase the Company's eligible accounts receivable. Upon any acquisition of accounts receivable, FastPay will advance the Company up to 80% of the gross value of the purchased accounts, up to a maximum of $4,000,000 in advances. Each account receivable purchased by FastPay will be subject to a factoring fee rate specified in the FastPay Agreement calculated as a percentage of the gross value of the account outstanding and additional fees for accounts outstanding over 30 days. The Company is subject to a concentration limitation on the percentage of debt from any single customer of 25% to the total amount outstanding on its purchased accounts, subject to an increase to 30% for one specific large customer. The Company is obligated to repurchase accounts remaining uncollected after a specified deadline, and FastPay will generally have full recourse against the Company in the event of nonpayment of any purchased accounts. The Company's obligations under the FastPay Agreement are secured by a first position security interest in its accounts receivable, deposit accounts and all proceeds therefrom. The FastPay Agreement contains covenants that are customary for agreements of this type and are primarily related to accounts receivable and audit rights. The Company is also required to provide FastPay with 30-day notice of any transaction that result, or would result in, a change of control as defined in the FastPay Agreement. The failure to satisfy covenants under the FastPay Agreement or the occurrence of other specified events that constitute an event of default, as defined, could result in the termination of the FastPay Agreement and/or the acceleration of the Company's obligations. The FastPay Agreement contains provisions relating to events of default that are customary for agreements of this type. The current FastPay Agreement has a term of 18 months and automatically renews thereafter for successive one-year terms, subject to earlier termination by written notice by the Company, provided all obligations are paid, including the payment of an early termination fee. At March 31, 2018, $1,287,176 of accounts receivable purchased by FastPay remain outstanding and are subject to repurchase under the terms of the FastPay Agreement. |
PUT WARRANT LIABILITY
PUT WARRANT LIABILITY | 3 Months Ended |
Mar. 31, 2018 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
PUT WARRANT LIABILITY | NOTE 9 PUT WARRANT LIABILITY As more fully described in Note 11, the Company issued Series A Warrants and Series B Warrants in connection with a securities purchase agreement dated January 4, 2017. At issuance, the Series A Warrants and the Series B Warrants were accounted for utilizing ASC 815 Derivatives and Hedging. The Company identified embedded derivatives related to the warrants issued. These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value of the derivatives as of the inception date of the warrants and to adjust the fair value as of each subsequent balance sheet date. At the inception of the warrants, the Company determined a fair value of $3,038,344 of the embedded derivatives. On January 4, 2017, the date of inception, the fair value of the embedded derivatives was determined using the Black-Scholes Model based on a risk-free interest rate of 2% for both the Series A Warrants and the Series B Warrants, an expected term of 5.5 years for the Series A Warrants and 5 years for the Series B Warrants, an expected volatility of 110% for the Series A Warrants and the Series B Warrants and a 0% dividend yield for the Series A Warrants and the Series B Warrants, respectively. Fair value at March 31, 2017 was estimated to be $1,143,781 and based on a risk-free interest rate of 1.875% for both the Series A Warrants and the Series B Warrants, an expected term of 5.25 years for the Series A Warrants and 4.75 years for the Series B Warrants, an expected volatility of 110% for the Series A Warrants and the Series B Warrants and a 0% dividend yield for the Series A Warrants and the Series B Warrants, respectively. During the period ended March 31, 2017, the decrease in the fair value of the warrant derivative liability of $1,894,563 was recorded as a gain on change in fair value of derivative liability. In July 2017, the Financial Accounting Standards Board (FASB) issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815): Part 1 Accounting for Certain Financial Instruments with Down Round Features and Part 2 Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with Scope Exception Topic 480, Distinguishing Liabilities from Equity, FASB Accounting Standards Codification The Company chose to early adopt the guidance under ASU 2017-11 for the year end December 31, 2017, and recognized all warrants issued in 2017 with a down round features as equity. Adjustments to the Companys previously issued financial statements were required for the retrospective application of this standard. As such the financial statements for three month period ended March 31, 2017 have been reclassified to reflect the adoption of ASU 2017-11. The put warrant liability is comprised of the following at March 31, 2017: March 31, 2017 Adjustments March 31, 2017 Initial derivative liability on issuance of put warrants $ 3,038,344 $ (3,038,344 ) $ Less accretion of put warrants (1,894,563 ) 1,894,563 Put warrant liability $ 1,143,781 $ (1,143,781 ) $ In April 2017, the Company repurchased the Series B Warrants for $2,500,000. As a result of the sale of the Debentures (see Note 10), the exercise price of the Series A Warrants issued to investors in our January 2017 private offering was reset to $2.245 per share. The Company recognized a loss on the repricing of these warrants amounting to $99,820. |
SECURED CONVERTIBLE DEBENTURES,
SECURED CONVERTIBLE DEBENTURES, NET | 3 Months Ended |
Mar. 31, 2018 | |
Convertible Debt [Abstract] | |
SECURED CONVERTIBLE DEBENTURES, NET | NOTE 10 SECURED CONVERTIBLE DEBENTURES, NET In April 2017, the Company entered into definitive securities purchase agreements (the Securities Purchase Agreements) with certain accredited investors (the Purchasers) for the purchase and sale of an aggregate of : (i) $5,000,000 principal amount of 12.5% secured convertible debentures (the Debentures); and (ii) five-year Series A warrants (the Debenture Warrants) representing the right to acquire up to 833,337 shares of our Class A common stock in a transaction exempt from registration under the Securities Act, in reliance on an exemption provided by Rule 506(b) of Regulation D and Section 4(a)(2) of the Securities Act. The Debentures, which mature three years from the date of issuance, pay interest in cash at the rate of 12.5% per annum, payable quarterly on January 1, April 1, July 1 and October 1, beginning on July 1, 2017. Our obligations under the Debentures are secured by a second position security interest in our accounts receivable and a first position security interest in the balance of our assets, and we are subject to continued compliance with certain financial covenants. The Debentures are convertible at the option of the holder into shares of our Class A common stock at an initial conversion price of $3.00 per share, subject to adjustment as hereinafter set forth. Subject to our compliance with certain equity conditions set forth in the Debentures, upon 20 trading days' notice to the holders we have the right to redeem the Debentures in cash at a 120% premium during the first year and a 110% premium during the remaining term of the Debentures. Upon any optional redemption, we are obligated to issue the holder five-year warrant Series B warrants, the terms of which will be identical to the Debenture Warrants, to purchase a number of shares of our Class A common stock as shall equal 50% of conversion shares issuable on an as-converted basis as if the principal amount of the Debenture had been converted immediately prior to the optional redemption. In the event of future financings by us, subject to certain exempt issuances, the holders have the right to cause us to allocate 20% of the proceeds we may receive as a mandatory redemption of a portion of the principal amount then outstanding. We are also required to redeem the Debentures upon our failure to maintain certain financial covenants which include a minimum monthly current ratio, a maximum quarterly corporate expense ratio, and maintain minimum quarterly revenue and EBITDA related to SRAXmd The Debenture also contains certain customary events of default (including, but not limited to, default in payment of principal or interest thereunder, breaches of covenants, agreements, representations or warranties thereunder, the occurrence of an event of default under certain material contracts of the Company, changes in control of the Company and the entering or filing of certain monetary judgments against the Company). Upon the occurrence of any such event of default, the outstanding principal amount of the Debenture, plus liquidated damages, interest and other amounts owing in respect thereof through the date of acceleration, shall become, at the holders election, immediately due and payable in cash. The Company is also subject to certain customary non-financial covenants under the Debenture. The Debenture holders were granted board observation rights so long as the lead investor continues to hold the Debentures. The Debenture Warrants are initially exercisable at $3.00 per share and, if at any time after the six-month anniversary of the issuance the underlying shares of our Class A common stock are not covered by an effective resale registration statement, the Debenture Warrants are exercisable on a cashless basis. The conversion price of the Debentures and the exercise price of the Debenture Warrants are subject to adjustments upon certain events, including stock splits, stock dividends, subsequent equity transactions (other than specified exempt issuances), subsequent rights offerings, and fundamental transactions, subject to a floor of $1.40 per share. If we fail to timely deliver the shares of our Class A common stock upon any conversion of the Debentures or exercise of the Debenture Warrants we will be subject to certain buy-in provisions. Pursuant to the terms of the Debentures and Debenture Warrants, a holder will not have the right to convert any portion of the Debentures or exercise any portion of the Debenture Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% of the number of shares of Class A common stock outstanding immediately after giving effect to such conversion or exercise, as such percentage ownership is determined in accordance with the terms of the Debentures and the Debenture Warrants; provided that after the Shareholder Approval Date, as defined below, at the election of a holder and notice to us such percentage ownership limitation may be increased or decreased to any other percentage, not to exceed 9.99%; provided that any increase will not be effective until the 61 st In accordance with the Nasdaq Marketplace Rules, until such time as our stockholders have approved the Securities Purchase Agreements and the transactions thereunder (the "Shareholder Approval Date"), we were not obligated to issue any shares of our Class A common stock upon any conversion of the Debentures and/or exercise of the Debenture Warrants, and the holders had no right to receive upon conversion and/or exercise thereof any shares of our Class A common stock, to the extent the issuance of such shares of Class A common stock would exceed 20% of our outstanding Class A common stock prior to the transaction. We held a special meeting of the shareholders on June 23, 2017 whereby we obtained approval of the Securities Purchase Agreements and the transactions thereunder. We agreed to file a registration statement registering the resale of the shares of our Class A common stock underlying the Debentures and the Debenture Warrants. Under the terms of the Securities Purchaser Agreements, we also granted the Purchasers of the Debentures the right to purchase an additional $3,000,000 of Debentures upon the same terms and conditions for a period beginning on the Shareholder Approval Date and expiring on earliest of the date that (a) the initial registration statement has been declared effective by the SEC, (b) all of the underlying shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement for our company to be in compliance with the current public information required under Rule 144 and without volume or manner-of-sale restrictions, (c) following the one year anniversary of the closing date provided that a holder of the underlying shares is not an affiliate of the Company or (d) all of the underlying shares may be sold pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act. The shares underlying the Debentures and Debenture Warrants were included in a resale registration statement on Form S-3 that was declared effective by the SEC in June 2017. Chardan Capital Markets, LLC (Chardan Capital), Noble Capital Markets, Inc. ("Noble") and Aspenwood Capital (an independent branch of Colorado Financial Services Corporation) (Aspenwood), all broker-dealers and members of FINRA, acted as either our placement agent or a finder in connection with the sale of the securities pursuant to the Securities Purchase Agreements. In addition, an affiliate of Noble purchased Debentures amounting to $720,000 and was issued Debenture Warrants to purchase 120,000 shares of our Class A common stock in this offering. We paid aggregate cash commissions amounting to $276,700 to these broker-dealers in connection with the sale of the Debentures. Additionally, we issued Chardan Capital placement agent warrants ("Chardan Placement Agent Warrants") to purchase 100,000 shares of our Class A common stock at an exercise price of $3.75 per share which are exercisable for 5.5 years commencing six months from the issuance date. We issued Noble placement agent warrants (Noble Placement Agent Warrants) to purchase up to 66,800 shares of our Class A common stock at an exercise price of $3.00 per share which will become exercisable six months from the date of issuance. We also issued Colorado Financial Service Corporation and its designees warrants (Aspenwood Warrants) to purchase 7,700 shares of our Class A common stock at an exercise price of $3.75 per share which are exercisable for 5.5 years commencing six months from the issuance date. We included the shares underlying the Chardan Placement Agent Warrants, the Noble Placement Agent Warrants, and the Aspenwood Warrants in the afore-described resale registration statement that was declared effective by the SEC in June 2017. The net proceeds to us from the offering, after deducting placement agent fees and estimated offering expenses, were approximately $4,566,405. We utilized $2,500,000 of the net proceeds to satisfy a put obligation under the Series B Warrants issued to investors in a registered direct offering that we conducted in January 2017 as described in Note 11. The balance of the net proceeds was used to pay down accounts payable and satisfy other working capital requirements. On October 26, 2017, the Company entered into definitive securities purchase agreements (the Securities Purchase Agreement) with certain prior accredited investors (the Purchasers) for the purchase and sale of an aggregate of: (i) $5,180,157.78 in principal amount of 12.5% secured convertible debentures (the "Debentures"); and (ii) five year Series A common stock purchase warrants (the Series A Warrants) representing the right to acquire up to 863,365 shares of our Class A common stock (the Offering) in a transaction exempt from registration under the Securities Act of 1933, as amended (the "Securities Act"), in reliance on the exemption provided by Rule 506(b) of Regulation D and Section 4(a)(2) of the Securities Act. The Offering includes (i) $2,000,000 of Debentures and Series A Warrants pursuant to the exercise of a green shoe (Green Shoe) provision contained in the transaction documents for the purchase and sale of the Prior Debentures (as defined below) and (ii) $3,180,157.78 of additional Debentures. The Debentures and Series A Warrants are being sold for a combination of cash and the cancellation of debt or receivables. The Debentures, which mature on April 21, 2020, pay interest in cash at the rate of 12.5% per annum, payable quarterly on January 1, April 1, July 1 and October 1, beginning on January 1, 2018. Our obligations under the Debentures are secured pari-passu with the debentures previously issued in April 2017 (Prior Debentures). The Debentures are convertible at the option of the holder into shares of our Class A common stock (Common Stock) at an initial conversion price of $3.00 per share, subject to adjustment as hereinafter described. The Debentures were issued in two series, Series A-1 Debentures (A-1 Debentures) and Series A-2 Debentures (A-2 Debentures). The Company will issue (i) $2,000,000 in A-1 Debentures and (ii) $3,180,157.78 in A-2 Debentures. The A-1 Debentures and A-2 Debentures are substantially the same except that the A-1 Debentures (i) we approved for issuance on June 23, 2017 by the shareholders of the Company pursuant to the Green Shoe and (ii) have a conversion price floor of $1.40 with regard to anti-dilution protection for subsequent equity sales at a price lower than 120% of the then applicable conversion price. The A-2 Debentures have a conversion price floor of $3.00 until such time as the Company receives shareholder approval for the transaction. On December 29, 2007, at our annual meeting of shareholders, we obtained approval of the transaction including the $1.40 floor price of the A-2 Debentures in the event of subsequent equity sales. Subject to our compliance with certain equity conditions (as more fully set forth in the Debentures), upon 20 trading days' notice to the holders we have the right to redeem the Debentures in cash at a 120% premium during the first year and a 110% premium during the remaining term of the Debentures. Upon any optional redemption, we are obligated to issue the holder Series B Common warrants, the terms of which will be identical to the Series A Warrants, to purchase a number of shares of our Common Stock equal to 50% of the conversion shares issuable on an as-converted basis as if the principal amount of the Debenture had been converted immediately prior to the optional redemption. In the event of future financings by us, subject to certain exempt issuances, the holders have the right to cause us to allocate 20% of the proceeds we receive to redeem a portion of the principal amount of the then outstanding Debentures. We are also required to redeem the Debentures, at the holders right, upon our failure to maintain certain financial covenants as further described in the Debentures. The Debentures also contain certain customary events of default (including, but not limited to, default in payment of principal or interest thereunder, breaches of covenants, agreements, representations or warranties thereunder, the occurrence of an event of default under certain material contracts of the Company, changes in control of the Company and the entering or filing of certain monetary judgments against the Company). Upon the occurrence of any such event of default, the outstanding principal amount of the Debenture for a premium, plus liquidated damages, interest and other amounts owing in respect thereof through the date of acceleration, shall become, at the holders election, immediately due and payable in cash. The Company is also subject to certain negative covenants under the Debenture, including but not limited to, the creation of certain debt obligations, liens on Company assets, amending its charter documents, repayment or repurchase of securities or certain debt of the Company, or the payment of dividends. The Series A Warrants are being issued as follows: (i) 333,335 issued pursuant to the Green Shoe and in connection with A-1 Debentures and (ii) 530,030 are being issued in connection with the A-2 Debentures. The Series A Warrants issued pursuant to the A-1 Debentures and A-2 Debentures have the same form. The Series A Warrants are initially exercisable at $3.00 per share and, are subject to cashless exercise after six months if the shares underlying the warrants are not subject to an effective resale registration statement. The Series A Warrants also contain anti-dilution protection for subsequent equity sales for a price lower than the then applicable exercise price, with a floor of $1.40. The conversion price of the Debentures and the exercise price of the Series A Warrants are subject to adjustments upon certain events, including stock splits, stock dividends, subsequent equity transactions (other than specified exempt issuances), subsequent rights offerings, and fundamental transactions, subject to the $1.40 and $3.00 floor described above). If we fail to timely deliver the shares of our Common Stock upon any conversion of the Debentures or exercise of the Series A Warrants, we will be subject to certain buy-in provisions. Pursuant to the terms of the Debentures and Series A Warrants, a holder will not have the right to convert any portion of the Debentures or exercise any portion of the Series A Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such conversion or exercise, as such percentage ownership is determined in accordance with the terms of the Debentures and the Series A Warrants; provided that at the election of a holder and notice to us such percentage ownership limitation may be increased to 9.99%; provided that any increase will not be effective until the 61 st The Company also agreed to use up to approximately $1.57 million in proceeds from the Offering to pay a $1.5 million put obligation of the outstanding Financing Warrant plus $.07 million in accrued interest on the amount outstanding. As of the date of the Securities Purchase Agreement, the Company had 8,605,018 shares of Common Stock issued and outstanding. As such, under the Nasdaq Market Place Rules, we are authorized to issue up to 19.99% of the issued and outstanding shares, or 1,720,143 shares. The shares of Common Stock underlying the A-2 Debentures and accompanying Series A Warrants are an aggregate of 1,590,081 shares of Common Stock. Notwithstanding, we are obligated to submit the Offering at the Shareholder Meeting for the purpose of reducing the floor conversion price of the A-2 Debentures as discussed above. In connection with this transaction, we will issue to our Placement Agents (as defined below), an aggregate of 183,337 common stock purchase warrants (PA Warrants) as follows: (i) 129,176 PA Warrants will have an exercise price of $3.75 per share and (ii) 54,161 PA Warrants will have an exercise price of $4.49 (the consolidated closing bid price of the Common Stock prior to the Securities Purchase Agreement). The PA Warrants are substantially similar to the Series A Warrants, except that the PA Warrants have a term of five and one half (5.5) years, are not exercisable until the six (6) month anniversary of the issuance date, and contain no anti-dilution protection. Pursuant to a registration rights agreement (Registration Rights Agreement), we have agreed to file a registration statement registering the resale of the shares of our common Stock underlying the Debentures and the Series A warrants within thirty (30) days from the date of the Registration Rights Agreement. We also agreed to have the registration statement declared effective within 90 days from the date of the Registration Rights Agreement and keep the registration statement continuously effective until the earlier of (i) the date after which all of the securities to be registered thereunder have been sold, or (ii) the date on which all the securities to be registered thereunder may be sold without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 under the Securities Act. We are also obligated to pay the Investors, as partial liquidated damages, a fee of 2.0% of each Investors subscription amount per month in cash upon the occurrence of certain events, including our failure to file and / or have the registration statement declared effective within the time periods provided. As a result of the registration statement not being declared effective, we have accrued partial liquidated damages of $103,862.16 as of April 30, 2018 (including interest accruing at 18% per annum). We will continue to incur additional liquidated damages on a monthly basis in the event that the registration statement is not declared effective. Chardan Capital Markets, LLC (Chardan Capital) acted as lead placement agent and Aspenwood Capital acted as co-placement agent ("Aspenwood"), in connection with the sale of the securities pursuant to the Securities Purchase Agreement. Pursuant to their respective engagement agreements, we will pay Chardan Capital a cash commission of $149,021.25 and Aspenwood a cash commission of $70,000. Pursuant to the discussion above, we also issued an aggregate of 160,000 PA Warrants to Chardan Capital and an aggregate of 23,337 PA Warrants to Aspenwood. We will include the shares underlying the Placement Agent Warrants in the resale registration statement we expect to file. Convertible Notes During the year ended December 31, 2017, certain holders of convertible debentures exercised their rights to convert amounts of principal totaling $3,335,000 into 1,111,667 shares of the Companys common equity. During the three month period ended March 31, 2018, the Company made no repayments on secured convertible debentures. During the three month period ended March 31, 2018, the Company recorded interest expense on the convertible debentures totaling $330,952. During the three month period ended March 31, 2018, the Company also recognized $332,658 of amortization of debt discount and deferred financing costs. Future minimum principal payments under senior secured convertible notes as of March 31, 2018, were as follows: Convertible Year Ending December 31, Notes 2018 $ 2019 2020 6,845,157 Total minimum principal payments 6,845,157 Less: debt discount and deferred debt issuance costs (4,801,353 ) Convertible notes, net $ 2,043,804 |
STOCKHOLDERS' EQUITY
STOCKHOLDERS' EQUITY | 3 Months Ended |
Mar. 31, 2018 | |
Stockholders' Equity Note [Abstract] | |
STOCKHOLDERS' EQUITY | NOTE 11 STOCKHOLDERS' EQUITY Common Stock On January 4, 2017, the Company entered a definitive securities purchase agreement with two fundamental institutional investors (the Investors) for the purchase and sale of an aggregate of: (i) 761,905 shares of the Companys Class A common stock; and (ii) five-year Series B Warrants (the Series B Warrants) representing the right to acquire up an additional 380,953 shares of our Class A common stock at an exercise price of $7.00 per share. The shares of our Class A common stock and the Series B Warrants were sold in a registered direct offering and we received gross proceeds of $3,980,001. Simultaneously we conducted a private placement with the same Investors for no additional consideration of Series A Warrants (the Series A Warrants) representing the right to acquire up to an additional 380,953 shares of our Class A common stock at an exercise price of $6.70 per share. The Series A Warrants are exercisable for five years commencing 6 months from the date of closing of the private sale of the Series A Warrants to the Investors. The exercise price of the Series A Warrants is subject to full ratchet adjustment in certain circumstances, subject to a floor price of $1.20 per share. The adjustment provisions under the terms of the Series A Warrants will be extinguished at such time as our Class A common stock trades at or above $10.00 per share for 20 consecutive trading days, subject to the satisfaction of certain equity conditions. In addition, if there is no effective registration statement covering the shares issuable upon the exercise of the Series A Warrants, the warrants are exercisable on a cashless basis. If we fail to timely deliver the shares underlying the warrants, we will be subject to certain buy-in provisions. As a result of the sale of the Debentures, the exercise price of the Series A Warrants issued to investors in our January 2017 private offering were reset to $2.245 per share. Beginning 100 days after the issuance date of the Series B Warrants, at any time the market price of our Class A common stock is less than $5.25 per share, the holders had the right to exercise the Series B Warrants on a cashless basis for shares of our Class A common stock calculated pursuant to a formula set forth in the Series B Warrants. We had the right, in lieu of delivery of such shares of our Class A common stock, to pay the holder of the Series B Warrants being exercised on a cashless basis, a specified amount in cash, with a maximum cash payment of $2,500,000. The holders of the Series B Warrants exercised their right in April 2017 and we repurchased the Series B Warrants for $2,500,000. Pursuant to the terms of the warrants, a holder of a warrant will not have the right to exercise any portion of the warrant if the holder (together with its affiliates) would beneficially own in excess of 9.99% of the number of shares of Class A common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the warrants; provided that at the election of a holder and notice to us such percentage ownership limitation may be increased or decreased to any other percentage, not to exceed 9.99%; provided that any increase will not be effective until the 61 st In the event of any extraordinary transaction, as described in the warrants and generally including any merger with or into another entity, sale of all or substantially all of our assets, tender offer or exchange offer, or reclassification of our common stock, the holder will have the right to have the warrants and all obligations and rights thereunder assumed by the successor or acquiring corporation. Also, at the election of the holder of each warrant, in the event of an extraordinary transaction, we or any successor entity may be required to repurchase such warrant for an amount of cash equal to the value of the warrant as determined in accordance with the Black Scholes option pricing model and the terms of the warrants. Pursuant to an engagement letter dated December 29, 2016 (the Placement Agent Agreement) by and between the Company and Chardan Capital Markets, Chardan Capital agreed to act as the Companys placement agent in connection with both the registered direct offering and a concurrent private placement. Pursuant to the Placement Agent Agreement, the Company paid Chardan Capital a cash fee equal to $160,000 (4% of the gross proceeds), as well as reimbursement of its expenses related to the offering in the amount of $15,000. In addition, the Company granted Chardan Capital a warrant to purchase 76,190 shares of Class A common stock (the Placement Warrants). The Placement Warrants have an exercise price of $6.50 per share and are exercisable for 5.5 years commencing six months from the issuance date. The shares underlying the Placement Warrants were included in a resale registration statement on Form S-3 that was declared effective by the SEC in June 2017. The net proceeds to the Company from the offering, after deducting placement agent fees and estimated offering expenses, were $3,830,000. The proceeds of the offering were used to satisfy the outstanding notes issued under the terms of the Financing Agreement. In connection with the January 2017 capital raise, Victory Park Management, LLC agreed not to exercise the put right under the Financing Warrant prior to May 20, 2017. Victory Park Management, LLC exercised the put right on May 22, 2017. We had had 45 days to satisfy this obligation which remains unpaid. On October 27, 2017, the Company satisfied this obligation in full utilizing a portion of net proceeds from a second debenture financing. The Class A shares of common stock and Series B Warrants were sold and issued pursuant to the Prospectus Supplement, dated January 4, 2017, to the Prospectus included in the Companys Registration Statement on Form S-3 (Registration No. 333-214644) filed with the SEC on November 16, 2016 and declared effective on November 28, 2016. In January 2017, in connection with an advisory agreement with kathy ireland Worldwide LLC ("kiWW"), the Company issued affiliates and designees of kiWW 100,000 shares of its Class A common stock valued at $678,000 In January 2017, we issued 3,858 shares of our Class A common stock valued at $12,500 to Mr. Derek J. Ferguson upon his appointment to our board of directors and the audit committee of the board. He is an accredited investor and the issuance was exempt from registration under the Securities Act pursuant to an exemption provided by Section 4(a)(2) of that act. In February 2017, the Company issued Mr. Steven Antebi 150,000 shares of our Class A common stock valued at $540,000 as compensation for services under the terms of a consulting agreement. He is a principal stockholder of the Company. In March 2017, we issued 51,667 shares of Class A common stock for vested stock awards. In March 2017, we issued 6,510 shares of our Class A common stock valued at $12,500 to Mr. Robert Jordan upon his appointment to our board of directors and the audit committee of the board. He is an accredited investor and the issuance was exempt from registration under the Securities Act pursuant to an exemption provided by Section 4(a)(2) of that act. In August 2017, we issued 200,000 shares in conjunction with our acquisition of certain intellectual property assets from Leapfrog Media Trading, Inc. On September 15, 2017, the Company entered an Investor Relations and Consulting Agreement (Consulting Agreement) with Al & J Media, Inc. (Consultant). The Company engaged the Consultant to provide certain consulting services on behalf of the Company as are more fully described in the Consulting Agreement. Under the terms of this agreement, which expires on December 15, 2017, the Company engaged Al & J Media, Inc. to provide a variety of advisory and consulting services to the Company, including introducing the Company to potential sources of media, marketing agreement(s) and/or other strategic alliances which may benefit the Company in the performance of implementing its business plan(s), including but not limited to radio and television media spots; various media publications; and internet podcasts. As compensation for such services, the Company issued Al & J Media, Inc. 75,000 shares valued at $97,500 of its Class A common stock on September 15, 2017. Between September 2017 and January 2018, we issued an aggregate of 225,000 shares of Class A common stock valued at $1,137,650 as consideration for media and marketing services. In October 2017, we issued 70,409 shares of our Class A common stock to Joseph P. Hannan, our chief financial officer, pursuant to his October 2017 employment agreement. The shares were issued pursuant to our 2016 equity compensation plan. In October 2017, we entered into securities purchase agreements to sell an aggregate of $5,180,158 of our 12.5% secured convertible debentures and issued 863,365 Series A Common Stock Purchase Warrants. The debentures mature on 4/21/2020, bear interest at an annual rate of 12.5%, payable quarterly on January 1, April 1, July 1, and October 1, beginning on January 1, 2018. Pursuant to the greenshoe provision contained in our April 2017 debenture offering, $2,000,000 of debentures were purchased pursuant to the greenshoe provision and the remaining $3,180,157.78 were purchased separately. Of the 863,365 warrants issued, a total of 333,335 were purchased pursuant to the greenshoe provision and 630,030 were purchased separately. The debentures are convertible into shares of our Class A common stock at $3.00 per share, subject to adjustment, and contain anti-dilution protection for subsequent financings and have a conversion price floor of $1.40 per share (pursuant to shareholder vote approving the offering that occurred on December 29, 2017). The warrants have an exercise price of $3.00 per share, subject to adjustment and contain anti-dilution protection for subsequent financings and have an exercise price floor of $1.40 per share. In connection with the offering we issued Chardan Capital Markets 160,000 placement agent warrants, of which: (i) 129,176 have an exercise price of $3.75 and (ii) 54,161 have an exercise price of $4.49 (. We also issued Aspenwood Capital 23,337 placement agent warrants with an exercise price of $3.75. All placement agent warrants have a term of five and a half years (exercisable beginning 6 months after issuance). In October 2017, multiple investors in the Companys April 2017 debenture financing converted an aggregate of $655,000 of debentures into 218,334 shares of Class A common stock. In October 2017, one investor in the Companys April 2017 debenture financing exercised 83,334 Series A common stock purchase warrants at an exercise price of $3.00 per share, resulting in gross proceeds to the Company of $250,002. In January 2018, we issued Colleen DiClaudio, a board member, 7,813 Class A common shares valued at $10,000 as payment for 2017 services on our board of directors. The shares were issued from our 2016 equity compensation plan In January 2018, we issued Hardy Thomas, a former board member, 7,195 Class A common shares valued at $10,000 as payment for 2017 services on our board of directors. The shares were issued from our 2016 equity compensation plan. In January 2018, we issued Marc Savas and Malcolm CasSelle each 3,774 Class A common shares valued at $10,000 as payment for their respective 2017 service on our board of directors. The shares were issued from our 2016 equity compensation plan. In January 2018, we issued Al & J Media an additional 150,000 shares for media consulting services pursuant to an extension of their September 2017 Consulting Agreement. In March 2018, we issued 6,667 shares of Class A common stock to one employee for vested stock awards. In March 2018, 122,950 shares of Class A common stock were awarded to one employee for sales performance achievement pursuant to our 2016 equity compensation plan. As of March 31, 2018, we have accrued as issuable to William Packer 3,774 shares of Class A common shares valued at $10,000 as payment for 2017 services on our board of directors. The shares will be issued from our 2016 equity compensation plan. Stock Awards During the three months ended March 31, 2018 and 2017, respectively, there were no new grants of stock awards made nor were any previously issued grants forfeited. During the three months ended March 31, 2018 and 2017, we recorded stock award expenses of $52,189 and $144,848; respectively. Stock Options and Warrants In November 2016, the Company entered an Investor Relations and Consulting Agreement (Consulting Agreement) with Market Street Investor Relations, LLC (Consultant). The Company engaged the Consultant to provide certain investor relations and public relations services on behalf of the Company as are more fully described in the Consulting Agreement. The term of the Consulting Agreement is for a period of six-months from the effective date and may be extended for an additional six-month term. In lieu of cash payments for the services rendered by the Consultant, the Company issued the Consultant a three year Class A common stock purchase warrant to purchase 400,000 shares of the Companys Class A common stock at an exercise price of $7.50 per share. The warrants vest based on specific milestones described within the Consulting Agreement. The value of the warrants at the date of grant was $1,390,264. At the direction of the Consultant, a warrant to purchase 200,000 shares was issued to the Consultant and a warrant to purchase 200,000 shares was issued to Steve Antebi (a principal stockholder in the Company). The Company also advanced the Consultant $100,000 on the effective date to cover anticipated expenses regarding the services to be performed by the Consultant. The Company paid the Consultant an additional $50,000 for expenses incurred during the nine months ended September 30, 2017. The Company is recognizing the value of the services rendered over the term of the Consulting Agreement. As of September 30, 2017, the Consultant had not yet attained any of the milestones contained within the Consulting Agreement and the Company reversed $275,637 of expense related to the Consulting Agreement. It was then determined that the Company would not extend the Consulting Agreement with the Consultant. During the three months ended March 31, 2017, an aggregate of 662,773 Common Stock purchase warrants, having exercise prices of between $5.00 and $10.00, per share, expired. On January 24, 2018, 176,400 Common Stock purchase warrants, having exercise prices of $7.50, per share, expired. During the three months ended March 31, 2018 and 2017, we recorded stock option expense of $83,941 and $33,419, respectively. Reverse Stock Split In September 2016, the Company completed a reverse stock split whereby each five shares of the Company's Class A common stock issued and outstanding, or held as treasury shares, immediately prior to the effective date of the reverse stock split became one share of its Class A common stock on the effective date of the reverse stock split. No fractional shares of Class A common stock were issued to any stockholder and all fractional shares which might otherwise be issuable because of the reverse stock split were rounded up to the nearest whole share. On the effective date of the reverse stock split, all outstanding options and warrants to purchase shares of the Company's Class A common stock were proportionally adjusted based upon the split ratio and became exercisable into one-fifth of the number of shares of the Company's Class A common stock as it was prior to the reverse stock split at an exercise price which is five times the exercise price prior to the reverse stock split. After the effective date of the reverse stock split, each certificate representing shares of pre-reverse stock split Class A common stock was deemed to represent one-fifth of a share of the post-reverse stock split Class A common stock, subject to rounding for fractional shares, and the records of the Company's transfer agent, Transfer Online, Inc., were adjusted to give effect to the reverse stock split. Following the effective date of the reverse stock split, the share certificates representing the pre-reverse stock split Class A common stock continue to be valid for the appropriate number of shares of post-reverse stock split Class A common stock, adjusted for rounding. These unaudited condensed consolidated financial statements give retroactive effect to the reverse stock split for all periods presented, unless otherwise specified. |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 3 Months Ended |
Mar. 31, 2018 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | NOTE 12 RELATED PARTY TRANSACTIONS On March 20, 2018, as we began to formally review potential strategic options for SRAXMD, we entered into certain retention and bonus agreements with SRAXMD employees, including Erin DeRuggiero, our chief innovations officer. Pursuant to the terms of the agreements with Ms. DeRuggiero, her employment agreement was terminated, and she became a consultant of the Company. The term of the consultancy expires in the second quarter of 2018, or upon the sale of the assets comprising SRAXmd, but may be extended by the parties. The terms of the consultancy are substantially similar to her prior employment agreement except that in the event of a sale of the SRAXmd business unit or substantially all of the assets thereof within 120 days from March 20, 2018, (i) we (or our assignee) have the right and the obligation to purchase all of Ms. DeRuggieros outstanding Class A common shares (514,667) at a price of $5.80 per share, or an aggregate of $2,985,069 and (ii) we will pay Ms. DeRuggiero, an amount equal to five percent (5%) of the cash consideration received from the sale of the SRAXmd business. The Company and Ms. DeRuggiero agreed to a customary release from any claims that may have arisen during her employment. On April 2, 2018, we issued a common stock purchase warrant to Kristoffer Nelson, our Chief Operating Officer and a member of our board of directors. The option entitles Mr. Nelson to purchase 100,000 shares of Class A Common Stock at a price per share of $5.78, has a term of three years and vests quarterly over a three (3) year period. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 3 Months Ended |
Mar. 31, 2018 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | NOTE 13 COMMITMENTS AND CONTINGENCIES Operating Leases The Company leases offices under operating leases that have expired and now operate on a month-to-month basis, subject to certain notice of termination provisions. Future minimum lease payments required under the operating leases amount to $50,636 for the year ended December 31, 2018. Rent expense for office space amounted to $68,070 and $40,212 for the three month period ended March 31, 2018 and 2017, respectively. Other Commitments In the ordinary course of business, the Company may provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company's breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise due to their status or service as directors, officers or employees. The Company has also agreed to indemnify certain former officers, directors and employees of acquired companies in connection with the acquisition of such companies. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors and employees of acquired companies, in certain circumstances. It is not possible to determine the maximum potential amount of exposure under these indemnification agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each agreement. Such indemnification agreements may not be subject to maximum loss clauses. Employment agreements We have entered employment agreements with key employees. These agreements may include provisions for base salary, guaranteed and discretionary bonuses and option grants. The agreements may contain severance provisions if the employees are terminated without cause, as defined in the agreements. Litigation From time to time, the Company may become subject to legal proceedings, claims and litigation arising in the ordinary course of business. In addition, the Company may receive letters alleging infringement of patent or other intellectual property rights. The Company is not currently a party to any material legal proceedings, nor is the Company aware of any pending or threatened litigation that would have a material adverse effect on the Company's business, operating results, cash flows or financial condition should such litigation be resolved unfavorably. |
FAIR VALUE OF FINANCIAL INSTRUM
FAIR VALUE OF FINANCIAL INSTRUMENTS | 3 Months Ended |
Mar. 31, 2018 | |
Fair Value Disclosures [Abstract] | |
FAIR VALUE OF FINANCIAL INSTRUMENTS | NOTE 14 FAIR VALUE OF FINANCIAL INSTRUMENTS The carrying amounts of certain financial instruments, including cash and cash equivalents, restricted cash and accounts payable, approximate their respective fair values due to the short-term nature of such instruments. The fair value of the 2017 Senior Secured Convertible Notes was $6,845,257 as of March 31, 2018. The fair value of the Convertible Notes was $6,845,257 as of December 31, 2017. All Convertible Notes fall within Level 3 of the fair value hierarchy as their value is based on the credit worthiness of the Company, which is an unobservable input. The Company used a Tsiveriotis - Fernandes model to value the 2017 Senior Convertible Notes as of March 31, 2018. Assets and Liabilities Measured at Fair Value on a Recurring Basis The Company evaluates its financial assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level in which to classify them for each reporting period. This determination requires significant judgments to be made. The following table summarizes the conclusions reached regarding fair value measurements as of March 31, 2018 and December 31, 2017: Quoted Prices in Active Markets Significant Other Significant Balance as of for Observable Unobservable March 31, Identical Assets Inputs Inputs 2018 (Level 1) (Level 2) (Level 3) Put Warrant liability $ $ $ $ Embedded Warrant Put Option Embedded Derivatives in Convertible Notes Total liabilities $ $ $ $ Securities: Certificates of deposit Money Market funds 189,888 189,888 U.S. government-sponsored agency securities Total assets $ 189,888 $ 189,888 $ $ Quoted Prices in Active Markets Significant Other Significant Balance as of for Observable Unobservable December 31, Identical Assets Inputs Inputs 2017 (Level 1) (Level 2) (Level 3) Put Option Liability $ $ $ $ Contingent Consideration Embedded Warrant Put Option Embedded Derivatives Total liabilities $ $ $ $ Securities: Certificates of deposit Money Market Funds 1,017,299 1,017,299 U.S. government-sponsored agency securities Total assets $ 1,017,299 $ 1,017,299 $ $ The Companys Warrant liability, embedded Warrant Put Option and the contingent consideration payments as well as the securities are measured at fair value on a recurring basis. As of March 31, 2018 and December 31, 2017, the Underwriter Warrant liability, Deerfield Warrant liability, embedded Warrant Put Option and the fundamental change and make-whole interest provisions embedded in the 2021 Notes are reported on the balance sheets in derivative and warrant liability, while the trading securities are reported on the balance sheets in marketable securities and long-term investments. As of December 31, 2016, the embedded Put Option is reported on the balance sheet in derivative and warrant liability. The Company used the settlement value for liability, the Put Option at December 31, 2016. The outstanding put option at December 31, 2016 was settled in January 2017. The Company incurred a warrant put option liability as a result of warrants issued in the January 2017 equity financing. This warrant put option liability was settled in April 2017 as it fair value of $2.5 million. Changes in the fair value of the Put Option liability in the 2016 was reflected in the statements of operations as a change in value adjustment. A reconciliation of the beginning and ending balances for the derivative and warrant liability measured at fair value on a recurring basis using significant unobservable inputs (Level 3) is as follows (in thousands): March 31, 2018 December 31, 2017 Balance as of beginning of period $ $ 1,500,000 Payments Adjustment to fair value Balance as of end of period $ $ 1,500,000 |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 3 Months Ended |
Mar. 31, 2018 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 15 SUBSEQUENT EVENTS None |
SUMMARY OF SIGNIFICANT ACCOUN21
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended |
Mar. 31, 2018 | |
Accounting Policies [Abstract] | |
Uses and Sources of Liquidity | Uses and Sources of Liquidity Our primary need for liquidity is to fund working capital requirements of our business, development of internally used software and for general corporate purposes, including debt repayment. Our general, selling and administrative expenses decreased from $4,409,807 for the three months ended March 31, 2017 to $4,130,258 for the three months ended March 31, 2018. We incurred a loss of $3,609,620 for the three months ended March 31, 2018 compared to a net loss of $3,920,922 for the three months ended March 31, 2017. At March 31, 2018, we had an accumulated deficit of $24,758,326. As of March 31, 2018, we had $189,888 in cash and cash equivalents and a deficit in working capital of $1,917,197 as compared to $1,017,299 in cash and cash equivalents and a surplus in working capital of $1,124,023 at December 31, 2017. We continue to experience a period of limited liquidity resulting from the complete repayment of senior secured notes associated with a financing agreement previously held by Victory Park Management, LLC and the repurchase of the Series B Warrants, both in April 2017. Additionally, in October 2017 we satisfied all amounts outstanding to Victory Park Management, LLC related to its put right for the repurchase of the Financing Warrant (as defined in Note 8), amounting to $1,500,000 plus accrued interest. See Note 8 for a further discussion of this obligation. We acknowledge that we continue to face a challenging competitive environment and while we continue to focus on our overall profitability, including managing expenses, we reported losses and have historically required funding of cash used in operating and investing activities with cash provided by financing activities. We expect that the actions initiated in the second half of 2017 will enhance our liquidity and financial flexibility in the first half of 2018. In late 2017, we announced several new revenue initiatives that could provide additional revenue growth opportunities anticipated to begin in the second half of 2018. In late 2017, we also announced that we had engaged outside advisors to evaluate potential strategic opportunities for our SRAXmd product group that could ultimately result in a sale of that product line, potentially adding additional liquidity for the Company. We believe that the actions discussed above are probable of occurring and will enable us to satisfy our estimated liquidity needs 12 months from the issuance of the financial statements. However, we cannot predict, with certainty, the outcome of our actions to generate liquidity or whether such actions would generate the expected liquidity as currently planned. If we continue to experience operating losses, and we are not able to generate additional liquidity through the mechanisms described above or through some combination of other actions, while not expected, we may not be able to access additional funds and we might need to secure additional sources of funds, which may or may not be available to us under terms and conditions that are favorable to our success. Additionally, a failure to generate additional liquidity could negatively impact our access to services that are important to the operation of our business. |
Effect of Reverse Stock Split on Presentation | Effect of Reverse Stock Split on Presentation In September 2016, the Company completed a 1 for 5 reverse stock split of our Class A common stock. These unaudited condensed consolidated financial statements give retroactive effect to the reverse stock split for all periods presented, unless otherwise specified. |
Effect of ASU No. 2017-11 on Previously Issued Financial Statements | Effect of ASU No. 2017-11 on Previously Issued Financial Statements In July 2017, the Financial Accounting Standards Board (FASB) issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815): Part 1 Accounting for Certain Financial Instruments with Down Round Features and Part 2 Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with Scope Exception Topic 480, Distinguishing Liabilities from Equity, FASB Accounting Standards Codification The Company early adopted the guidance under ASU 2017-11 for the year end December 31, 2017, and recognized warrants issued in 2017 with a down round feature as equity. Adjustments to the Companys previously issued financial statements were required for the retrospective application of this standard. As such the financial statements for three month period ended March 31, 2017 have been reclassified to reflect the adoption of ASU 2017-11. March 31, 2017 March 31, 2017 As Reported Adjustments As Adjusted Assets Current assets: Cash and cash equivalents 119,331 119,331 Accounts receivable, net 6,578,747 6,578,747 Prepaid expenses 330,432 330,432 Other current assets 6,488 6,488 Total current assets 7,034,998 7,034,998 Property and equipment, net 58,079 58,079 Goodwill 15,644,957 15,644,957 Intangibles assets, net 924,011 924,011 Other assets 34,659 34,659 Total assets 23,696,704 23,696,704 Liabilities and Stockholders' Equity Current liabilities: Accounts payable and accrued expenses 12,960,933 12,960,933 Note payable, net of unamortized costs Put warrant liability 1,143,781 (1,143,781 ) Put liability 1,500,000 1,500,000 Total current liabilities 15,604,714 (1,143,781 ) 14,460,933 Commitments and contingencies (Note 11) Stockholders' equity: Preferred stock, authorized 50,000,000 shares, $0.001 par value, no shares issued or outstanding at March 31, 2017 and December 31, 2016, respectively Class A common stock, authorized 50,000,000 shares, $0.001 par value, 8,025,017 and 6,951,077 shares issued and outstanding at March 31, 2017 and December 31, 2016, respectively 8,025 8,025 Class B common stock, authorized 9,000,000 shares, $0.001 par value, no shares issued or outstanding at March 31, 2017 and December 31, 2016, respectively Common stock to be issued Additional paid in capital 24,500,328 - 24,500,328 Accumulated deficit (16,416,363 ) 1,143,781 (15,272,582 ) Total stockholders' equity 8,091,990 1,143,781 9,235,771 Total liabilities and stockholders' equity 23,696,704 - 23,696,704 Three Month Period ended Three Month Period ended March 31, 2017 March 31, 2017 As Reported Adjustments As Adjusted Revenue 5,326,163 5,326,163 Cost of revenue 3,279,120 3,279,120 Gross profit 2,047,043 2,047,043 Operating expense General, selling and administrative expense 4,409,807 4,409,807 Write-off of non-compete agreement 468,751 468,751 Restructuring costs 377,961 377,961 Total operating expense, net 5,256,519 5,256,519 Loss from operations (3,209,476 ) (3,209,476 ) Other income (expense): Interest expense: Interest expense (133,306 ) (133,306 ) Amortization of debt issuance costs (578,140 ) (578,140 ) Total interest expense (711,446 ) (711,446 ) Accretion of put warrants 1,894,563 (1,894,563 ) Total other income (expense) 1,183,117 (1,894,563 ) (711,446 ) Loss before provision for income taxes (2,026,359 ) (1,894,563 ) (3,920,922 ) Provision for income taxes Net loss (2,026,359 ) (1,894,563 ) (3,920,922 ) Net loss per share, basic and diluted (0.26 ) (0.24 ) (0.50 ) Weighted average shares outstanding, basic and diluted 7,844,127 7,844,127 Three Month Period Ended Three Month Period ended March 31, 2017 March 31, 2017 As Reported Adjustments As Adjusted Cash flows from operating activities Net loss (2,026,359 ) (1,894,563 ) (3,920,922 ) Adjustments to reconcile net loss to net cash used in operating activities: Stock based compensation 512,442 512,442 Amortization of debt issuance costs 578,140 578,140 Accretion of put warrants (1,894,563 ) 1,894,563 Write-off of non-compete agreement 468,751 468,751 Provision for bad debts (8,277 ) (8,277 ) Depreciation expense 3,234 3,234 Amortization of intangibles 107,720 107,720 Changes in operating assets and liabilities: Accounts receivable 1,840,549 1,840,549 Prepaid expenses 2,071 2,071 Other current assets Accounts payable and accrued expenses (195,150 ) (195,150 ) Unearned revenue Net cash used in operating activities (611,442 ) (611,442 ) Cash flows from investing activities Purchase of equipment (5,821 ) (5,821 ) Development of software (135,241 ) (135,241 ) Net cash used in investing activities (141,062 ) (141,062 ) Cash flows from financing activities Proceeds from the issuance of common stock 3,820,001 3,820,001 Proceeds from notes payable Repayments of note payable and PIK interest (3,996,928 ) (3,996,928 ) Net cash (used in) provided by financing activities (176,927 ) (176,927 ) Net (decrease) increase in cash and cash equivalents (929,431 ) (929,431 ) Cash and cash equivalents, beginning of period 1,048,762 1,048,762 Cash and cash equivalents, end of period 119,331 119,331 Supplemental schedule of cash flow information Cash paid for interest 550,695 550,695 Cash paid for taxes |
Principles of Consolidation | Principles of Consolidation The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All material intercompany transactions and balances have been eliminated in consolidation. |
Use of Estimates | Use of Estimates The unaudited condensed consolidated financial statements have been prepared in conformity with GAAP and requires management of the Company to make estimates and assumptions in the preparation of these unaudited condensed consolidated financial statements that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting periods. Actual results could differ from these estimates and assumptions. The most significant areas that require management judgment and which are susceptible to possible change in the near term include the Company's revenue recognition, allowance for doubtful accounts and sales credits, stock-based compensation, income taxes, goodwill, other intangible assets, put rights and valuation of liabilities. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term highly liquid investments with a remaining maturity at the date of purchase of three months or less to be cash equivalents. |
Revenue Recognition | Revenue Recognition The Company recognizes revenue when the following criteria have been met: persuasive evidence of an arrangement exists; no significant Company obligations remain; collection of the related receivable is reasonably assured; and the fees are fixed or determinable. The Company acts as a principal in revenue transactions as the Company is the primary obligor in the transactions. As such, revenue is recognized on a gross basis, and media and publisher expenses that are directly related to a revenue-generating event are recorded as a component of cost of revenue. |
Cost of Revenue | Cost of Revenue Cost of revenue consists of payments to media providers and website publishers that are directly related to either a revenue-generating event or project and application design costs. The Company becomes obligated to make payments related to media providers and website publishers in the period the advertising impressions, click-through, actions or lead-based information are delivered or occur. Such expenses are classified as cost of revenue in the corresponding period in which the revenue is recognized in the accompanying unaudited condensed consolidated statements of operations. |
Accounts Receivable | Accounts Receivable Credit is extended to customers based on an evaluation of their financial condition and other factors. Management periodically assesses the Company's accounts receivable and, if necessary, establishes an allowance for estimated uncollectible amounts. Accounts determined to be uncollectible are charged to operations when that determination is made. The Company does not require collateral. Allowance for doubtful accounts was $59,278 and $59,703 at March 31, 2018 and December 31, 2017, respectively. |
Concentration of Credit Risk, Significant Customers and Supplier Risk | Concentration of Credit Risk, Significant Customers and Supplier Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and accounts receivable. Cash and cash equivalents are deposited with financial institutions within the United States. The Company has not experienced any loss on these accounts. The balances are maintained in demand accounts to minimize risk. At March 31, 2018, three customers accounted for more than 10% of the accounts receivable balance for a total of 57.4%. At December 31, 2017, four customers accounted for more than 10% of the accounts receivable balance for a total of 59.5%. For the three months ended March 31, 2018, two customers accounted for more than 10% of total revenue for a total of 44.9%. For the three months ended March 31, 2017, one customer accounted for 25.9% of total revenue. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The accounting standard for fair value measurements provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Companys principal or, in absence of a principal, most advantageous market for the specific asset or liability. The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows: ● Level 1 — ● Level 2 — ● Level 3 — The Company's financial instruments, including cash and cash equivalents, net accounts receivable, accounts payable and accrued expenses, are carried at historical cost. At March 31, 2018 and December 31, 2017, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments. Derivative instruments are carried at fair value, generally estimated using the Black Scholes Merton model. |
Property and equipment | Property and equipment Property and equipment is stated at cost less accumulated depreciation. Depreciation is provided on the straight-line basis over the estimated useful lives of the assets of three to seven years. Expenditures for repair and maintenance which do not materially extend the useful lives of property and equipment are charged to operations. When property or equipment is sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the respective accounts with the resulting gain or loss reflected in operations. Management periodically reviews the carrying value of its property and equipment for impairment. |
Intangible assets | Intangible assets Intangible assets consist of intellectual property, a non-complete agreement, and internally developed software and are stated at cost less accumulated amortization. Amortization is provided for on the straight-line basis over the estimated useful lives of the assets of three to six years. During 2016, the Company began capitalizing the costs of developing internal-use computer software, including directly related payroll costs. The Company capitalizes costs incurred during the application development stage of internal-use software and amortize these costs over the estimated useful life. Upgrades and enhancements are capitalized if they result in added functionality which enable the software to perform tasks it was previously incapable of performing. Software maintenance, training, data conversion, and business process reengineering costs are expensed in the period in which they are incurred. The Company capitalizes the costs of developing internal-use computer software, including directly related payroll costs. The Company amortizes costs associated with its internally developed software over periods up to three years, beginning when the software is ready for its intended use. |
Business Combinations | Business Combinations For all business combinations (whether partial, full or step acquisitions), the Company records 100% of all assets and liabilities of the acquired business, including goodwill, generally at their fair values; contingent consideration, if any, is recognized at its fair value on the acquisition date and, for certain arrangements, changes in fair value are recognized in earnings until settlement and acquisition-related transaction and restructuring costs are expensed rather than treated as part of the cost of the acquisition. |
Goodwill and annual impairment testing period | Goodwill and annual impairment testing period Goodwill is comprised of the purchase price of business combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill is not amortized. The Company assesses goodwill for impairment at least annually, or when events or changes in the business environment indicate the carrying value may not be fully recoverable. The Company also has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads the Company to determine that it is more likely than not (that is, a likelihood of more than 50%) that goodwill is impaired. If the Company chooses to first assess qualitative factors and it is determined that it is not more likely than not goodwill is impaired, the Company is not required to take further action to test for impairment. The Company also has the option to bypass the qualitative assessment and perform only the quantitative impairment test, which the Company may choose to do in some periods but not in others. The Company performs its annual impairment review as of December 31 st The Company had historically performed its annual goodwill and impairment assessment on September 30 th st When evaluating the potential impairment of goodwill, management first assess a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company's products and services, regulatory and political developments, entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company's reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we then proceed to a two-step impairment testing methodology using the income approach (discounted cash flow method). In the first step of the two-step testing methodology, we compare the carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows. If the carrying value of a reporting unit exceeds its fair value, we then complete the second step of the impairment test to determine the amount of impairment to be recognized. In the second step, we estimate an implied fair value of the reporting unit's goodwill by allocating the fair value of the reporting unit to 100% of the assets and liabilities other than goodwill (including any unrecognized intangible assets). If the carrying value of a reporting unit's goodwill exceeds its implied fair value, the Company records an impairment loss equal to the difference in that period. When required, we arrive at our estimates of fair value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or estimates for future cash flows could produce different results. The impairment charge represents the excess of the carrying amount of the goodwill recorded in the acquisition over the implied fair value of the goodwill. The implied fair value of the goodwill is the residual fair value based on an income approach that utilized a discounted cash flow model based on revenue and profit forecasts. The Company performed its annual impairment test and no impairment of goodwill has been recorded during the three months ended March 31, 2018 or 2017, respectively. |
Long-lived Assets | Long-lived Assets Management evaluates the recoverability of the Company's identifiable intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists. Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable include, but are not limited to: significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; a significant decline in the Company's stock price for a sustained period of time; and changes in the Company's business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets. If impairment is indicated based on a comparison of the assets' carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. No impairments have been recorded regarding its identifiable intangible assets or other long-lived assets during the three months ended March 31, 2018 or 2017, respectively. |
Derivatives | Derivatives The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic No. 480, Distinguishing Liabilities From Equity Derivatives and Hedging |
Loss Per Share | Loss Per Share We use Accounting Standards Codification (ASC) 260, " Earnings Per Share There were 5,053,258 common share equivalents at March 31, 2018 and 3,619,331 common share equivalents at March 31, 2017. For the three months ended March 31, 2018 and 2017, respectively, these potential shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would reduce net loss per share. |
Income Taxes | Income Taxes We utilize ASC 740 Income Taxes The Company recognizes the impact of a tax position in the consolidated financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense. |
Stock-Based Compensation | Stock-Based Compensation We account for our stock based compensation under ASC 718 " Compensation Stock Compensation We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods. Common stock awards The Company grants common stock awards to non-employees in exchange for services provided. The Company measures the fair value of these awards using the fair value of the services provided or the fair value of the awards granted, whichever is more reliably measurable. The fair value measurement date of these awards is generally the date the performance of services is complete. The fair value of the awards is recognized on a straight-line basis as services are rendered. The share-based payments related to common stock awards for the settlement of services provided by non-employees is recorded on the consolidated statement of comprehensive loss in the same manner and charged to the same account as if such settlements had been made in cash. Warrants In connection with certain financing, consulting and collaboration arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are standalone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded at fair value as a reduction in additional paid-in capital of the common stock issued. All other warrants are recorded at fair value as expense over the requisite service period or at the date of issuance, if there is not a service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 11, Stockholders Equity . |
Business Segments | Business Segments The Company uses the "management approach" to identify its reportable segments. The management approach designates the internal organization used by management for making operating decisions and assessing performance as the basis for identifying the Company's reportable segments. Using the management approach, the Company determined that it has one operating segment due to business similarities and similar economic characteristics. |
SUMMARY OF SIGNIFICANT ACCOUN22
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Accounting Policies [Abstract] | |
Schedule of Restated Financial Statements from Adoption of ASU 2017-11 | The Company early adopted the guidance under ASU 2017-11 for the year end December 31, 2017, and recognized warrants issued in 2017 with a down round feature as equity. Adjustments to the Companys previously issued financial statements were required for the retrospective application of this standard. As such the financial statements for three month period ended March 31, 2017 have been reclassified to reflect the adoption of ASU 2017-11. March 31, 2017 March 31, 2017 As Reported Adjustments As Adjusted Assets Current assets: Cash and cash equivalents 119,331 119,331 Accounts receivable, net 6,578,747 6,578,747 Prepaid expenses 330,432 330,432 Other current assets 6,488 6,488 Total current assets 7,034,998 7,034,998 Property and equipment, net 58,079 58,079 Goodwill 15,644,957 15,644,957 Intangibles assets, net 924,011 924,011 Other assets 34,659 34,659 Total assets 23,696,704 23,696,704 Liabilities and Stockholders' Equity Current liabilities: Accounts payable and accrued expenses 12,960,933 12,960,933 Note payable, net of unamortized costs Put warrant liability 1,143,781 (1,143,781 ) Put liability 1,500,000 1,500,000 Total current liabilities 15,604,714 (1,143,781 ) 14,460,933 Commitments and contingencies (Note 11) Stockholders' equity: Preferred stock, authorized 50,000,000 shares, $0.001 par value, no shares issued or outstanding at March 31, 2017 and December 31, 2016, respectively Class A common stock, authorized 50,000,000 shares, $0.001 par value, 8,025,017 and 6,951,077 shares issued and outstanding at March 31, 2017 and December 31, 2016, respectively 8,025 8,025 Class B common stock, authorized 9,000,000 shares, $0.001 par value, no shares issued or outstanding at March 31, 2017 and December 31, 2016, respectively Common stock to be issued Additional paid in capital 24,500,328 - 24,500,328 Accumulated deficit (16,416,363 ) 1,143,781 (15,272,582 ) Total stockholders' equity 8,091,990 1,143,781 9,235,771 Total liabilities and stockholders' equity 23,696,704 - 23,696,704 Three Month Period ended Three Month Period ended March 31, 2017 March 31, 2017 As Reported Adjustments As Adjusted Revenue 5,326,163 5,326,163 Cost of revenue 3,279,120 3,279,120 Gross profit 2,047,043 2,047,043 Operating expense General, selling and administrative expense 4,409,807 4,409,807 Write-off of non-compete agreement 468,751 468,751 Restructuring costs 377,961 377,961 Total operating expense, net 5,256,519 5,256,519 Loss from operations (3,209,476 ) (3,209,476 ) Other income (expense): Interest expense: Interest expense (133,306 ) (133,306 ) Amortization of debt issuance costs (578,140 ) (578,140 ) Total interest expense (711,446 ) (711,446 ) Accretion of put warrants 1,894,563 (1,894,563 ) Total other income (expense) 1,183,117 (1,894,563 ) (711,446 ) Loss before provision for income taxes (2,026,359 ) (1,894,563 ) (3,920,922 ) Provision for income taxes Net loss (2,026,359 ) (1,894,563 ) (3,920,922 ) Net loss per share, basic and diluted (0.26 ) (0.24 ) (0.50 ) Weighted average shares outstanding, basic and diluted 7,844,127 7,844,127 Three Month Period Ended Three Month Period ended March 31, 2017 March 31, 2017 As Reported Adjustments As Adjusted Cash flows from operating activities Net loss (2,026,359 ) (1,894,563 ) (3,920,922 ) Adjustments to reconcile net loss to net cash used in operating activities: Stock based compensation 512,442 512,442 Amortization of debt issuance costs 578,140 578,140 Accretion of put warrants (1,894,563 ) 1,894,563 Write-off of non-compete agreement 468,751 468,751 Provision for bad debts (8,277 ) (8,277 ) Depreciation expense 3,234 3,234 Amortization of intangibles 107,720 107,720 Changes in operating assets and liabilities: Accounts receivable 1,840,549 1,840,549 Prepaid expenses 2,071 2,071 Other current assets Accounts payable and accrued expenses (195,150 ) (195,150 ) Unearned revenue Net cash used in operating activities (611,442 ) (611,442 ) Cash flows from investing activities Purchase of equipment (5,821 ) (5,821 ) Development of software (135,241 ) (135,241 ) Net cash used in investing activities (141,062 ) (141,062 ) Cash flows from financing activities Proceeds from the issuance of common stock 3,820,001 3,820,001 Proceeds from notes payable Repayments of note payable and PIK interest (3,996,928 ) (3,996,928 ) Net cash (used in) provided by financing activities (176,927 ) (176,927 ) Net (decrease) increase in cash and cash equivalents (929,431 ) (929,431 ) Cash and cash equivalents, beginning of period 1,048,762 1,048,762 Cash and cash equivalents, end of period 119,331 119,331 Supplemental schedule of cash flow information Cash paid for interest 550,695 550,695 Cash paid for taxes |
PROPERTY AND EQUIPMENT (Tables)
PROPERTY AND EQUIPMENT (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property and Equipment | Property and equipment consists of the following at March 31, 2018 and December 31, 2017: March 31, 2018 December 31, 2017 Office equipment $ 272,207 $ 251,415 Accumulated depreciation (106,309 ) (96,869 ) Property and equipment, net $ 165,898 $ 154,546 |
INTANGIBLE ASSETS (Tables)
INTANGIBLE ASSETS (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Intangible assets | Intangible assets consist of the following: March 31, 2018 December 31, 2017 Non-compete agreement $ 1,250,000 $ 1,250,000 Intellectual property 756,000 756,000 Acquired software - Leapfrog 617,069 617,069 Internally developed software 985,914 754,140 3,608,983 3,377,209 Accumulated amortization (1,900,634 ) (1,734,449 ) Carrying value $ 1,708,349 $ 1,642,760 |
Schedule of Estimated Future Amortization Expense | The estimated future amortization expense for the remainder of 2018 and the years ended December 31 thereafter, are as follows: Remainder of 2018 $ 514,592 2019 662,094 2020 205,690 2021 325,973 $ 1,708,349 |
ACCOUNTS PAYABLE AND ACCRUED 25
ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Accounts Payable and Accrued Liabilities [Abstract] | |
Schedule of Accounts Payable and Accrued Expenses | Accounts payable and accrued expenses are comprised of the following: March 31, 2018 December 31, 2017 Accounts payable, trade $ 3,145,279 $ 2,858,871 Accrued expenses 1,440,440 1,800,621 Accrued compensation 94,128 256,164 Accrued commissions 2,947 95,159 Total $ 4,682,794 $ 5,010,815 |
PUT WARRANT LIABILITY (Tables)
PUT WARRANT LIABILITY (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Put Warrant Liability | The put warrant liability is comprised of the following at March 31, 2017: March 31, 2017 Adjustments March 31, 2017 Initial derivative liability on issuance of put warrants $ 3,038,344 $ (3,038,344 ) $ Less accretion of put warrants (1,894,563 ) 1,894,563 Put warrant liability $ 1,143,781 $ (1,143,781 ) $ |
FAIR VALUE OF FINANCIAL INSTR27
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) | 3 Months Ended |
Mar. 31, 2018 | |
Fair Value Disclosures [Abstract] | |
Schedule of assets and liabilities measured at fair value on a recurring basis | The following table summarizes the conclusions reached regarding fair value measurements as of March 31, 2018 and December 31, 2017: Quoted Prices in Active Markets Significant Other Significant Balance as of for Observable Unobservable March 31, Identical Assets Inputs Inputs 2018 (Level 1) (Level 2) (Level 3) Put Warrant liability $ $ $ $ Embedded Warrant Put Option Embedded Derivatives in Convertible Notes Total liabilities $ $ $ $ Securities: Certificates of deposit Money Market funds 189,888 189,888 U.S. government-sponsored agency securities Total assets $ 189,888 $ 189,888 $ $ Quoted Prices in Active Markets Significant Other Significant Balance as of for Observable Unobservable December 31, Identical Assets Inputs Inputs 2017 (Level 1) (Level 2) (Level 3) Put Option Liability $ $ $ $ Contingent Consideration Embedded Warrant Put Option Embedded Derivatives Total liabilities $ $ $ $ Securities: Certificates of deposit Money Market Funds 1,017,299 1,017,299 U.S. government-sponsored agency securities Total assets $ 1,017,299 $ 1,017,299 $ $ |
Schedule of reconciliation of derivative and warrant liability measured at fair value | A reconciliation of the beginning and ending balances for the derivative and warrant liability measured at fair value on a recurring basis using significant unobservable inputs (Level 3) is as follows (in thousands): March 31, 2018 December 31, 2017 Balance as of beginning of period $ $ 1,500,000 Payments Adjustment to fair value Balance as of end of period $ $ 1,500,000 |
SUMMARY OF SIGNIFICANT ACCOUN28
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||
Apr. 30, 2017USD ($) | Mar. 31, 2018USD ($)Itemshares | Mar. 31, 2017USD ($)shares | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($) | |
General, selling and administrative expense | $ 4,130,258 | $ 4,409,807 | |||
Net loss | $ 3,609,620 | 3,920,922 | |||
Reverse stock split ratio | 5 | ||||
Allowance for doubtful accounts | $ 59,278 | $ 59,703 | |||
Number of operating segments | Item | 1 | ||||
Antidilutive common share equivalents | shares | 5,053,258 | 3,619,331 | |||
Impairment of long-lived assets | |||||
Accumulated deficit | 24,758,326 | $ 15,272,582 | $ 21,148,706 | ||
Cash and cash equivalents | 189,888 | $ 119,331 | 1,017,299 | $ 1,048,762 | |
Working capital deficit | $ 1,917,197 | $ 1,124,023 | |||
Minimum [Member] | |||||
Property and equipment estimated useful life | 3 years | ||||
Intangible assets estimated useful life | 3 years | ||||
Maximum [Member] | |||||
Property and equipment estimated useful life | 7 years | ||||
Intangible assets estimated useful life | 6 years | ||||
Accounts Receivable [Member] | Customer Concentration Risk [Member] | |||||
Concentration risk percentage | 57.40% | 59.50% | |||
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | |||||
Concentration risk percentage | 44.90% | 25.90% | |||
Financing Agreement [Member] | Victory Park Management, LLC [Member] | |||||
Value of put right for the repurchase of the Financing Warrant exercised | $ 1,500,000 |
SUMMARY OF SIGNIFICANT ACCOUN29
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Balance Sheet) (Details) - USD ($) | Mar. 31, 2018 | Dec. 31, 2017 | Mar. 31, 2017 | Dec. 31, 2016 |
Current assets: | ||||
Cash and cash equivalents | $ 189,888 | $ 1,017,299 | $ 119,331 | $ 1,048,762 |
Accounts receivable, net | 1,734,058 | 4,348,305 | 6,578,747 | |
Prepaid expenses | 540,753 | 468,336 | 330,432 | |
Other current assets | 300,898 | 300,898 | 6,488 | |
Total current assets | 2,765,597 | 6,134,838 | 7,034,998 | |
Property and equipment, net of accumulated depreciation | 165,898 | 154,546 | 58,079 | |
Goodwill | 15,644,957 | 15,644,957 | 15,644,957 | |
Intangibles - net | 1,708,349 | 1,642,760 | 924,011 | |
Other assets | 32,043 | 28,598 | 34,659 | |
Total assets | 20,316,844 | 23,605,699 | 23,696,704 | |
Current liabilities: | ||||
Accounts payable and accrued expenses | 4,682,794 | 5,010,815 | 12,960,933 | |
Note payable, net of unamortized costs | ||||
Put warrant liability | ||||
Put liability | 1,500,000 | 1,500,000 | 1,500,000 | |
Total current liabilities | 4,682,794 | 5,010,815 | 14,460,933 | |
Secured convertible debentures, net | 2,043,804 | 1,711,146 | ||
Total liabilities | 6,726,598 | 6,721,961 | ||
Commitments and contingencies (Note 11) | ||||
Stockholders' equity | ||||
Preferred stock, authorized 50,000,000 shares, $0.001 par value, no shares issued or outstanding at March 31, 2017 and December 31, 2016, respectively | ||||
Common stock to be issued | 10,000 | 879,500 | ||
Additional paid in capital | 38,328,359 | 37,143,033 | 24,500,328 | |
Accumulated deficit | (24,758,326) | (21,148,706) | (15,272,582) | |
Total stockholders' equity | 13,590,246 | 16,883,738 | 9,235,771 | |
Total liabilities and stockholders' equity | 20,316,844 | 23,605,699 | 23,696,704 | |
Common Class A [Member] | ||||
Stockholders' equity | ||||
Common stock | 10,213 | 9,911 | 8,025 | |
Common Class B [Member] | ||||
Stockholders' equity | ||||
Common stock | ||||
As Reported [Member] | ||||
Current assets: | ||||
Cash and cash equivalents | 119,331 | 1,048,762 | ||
Accounts receivable, net | 6,578,747 | |||
Prepaid expenses | 330,432 | |||
Other current assets | 6,488 | |||
Total current assets | 7,034,998 | |||
Property and equipment, net of accumulated depreciation | 58,079 | |||
Goodwill | 15,644,957 | |||
Intangibles - net | 924,011 | |||
Other assets | 34,659 | |||
Total assets | 23,696,704 | |||
Current liabilities: | ||||
Accounts payable and accrued expenses | 12,960,933 | |||
Note payable, net of unamortized costs | ||||
Put warrant liability | 1,143,781 | |||
Put liability | 1,500,000 | |||
Total current liabilities | 15,604,714 | |||
Commitments and contingencies (Note 11) | ||||
Stockholders' equity | ||||
Preferred stock, authorized 50,000,000 shares, $0.001 par value, no shares issued or outstanding at March 31, 2017 and December 31, 2016, respectively | ||||
Common stock to be issued | ||||
Additional paid in capital | 24,500,328 | |||
Accumulated deficit | (16,416,363) | |||
Total stockholders' equity | 8,091,990 | |||
Total liabilities and stockholders' equity | 23,696,704 | |||
As Reported [Member] | Common Class A [Member] | ||||
Stockholders' equity | ||||
Common stock | 8,025 | |||
As Reported [Member] | Common Class B [Member] | ||||
Stockholders' equity | ||||
Common stock | ||||
Adjustments [Member] | ||||
Current assets: | ||||
Cash and cash equivalents | ||||
Accounts receivable, net | ||||
Prepaid expenses | ||||
Other current assets | ||||
Total current assets | ||||
Property and equipment, net of accumulated depreciation | ||||
Goodwill | ||||
Intangibles - net | ||||
Other assets | ||||
Total assets | ||||
Current liabilities: | ||||
Accounts payable and accrued expenses | ||||
Note payable, net of unamortized costs | ||||
Put warrant liability | (1,143,781) | |||
Put liability | ||||
Total current liabilities | (1,143,781) | |||
Commitments and contingencies (Note 11) | ||||
Stockholders' equity | ||||
Preferred stock, authorized 50,000,000 shares, $0.001 par value, no shares issued or outstanding at March 31, 2017 and December 31, 2016, respectively | ||||
Common stock to be issued | ||||
Additional paid in capital | ||||
Accumulated deficit | 1,143,781 | |||
Total stockholders' equity | 1,143,781 | |||
Total liabilities and stockholders' equity | ||||
Adjustments [Member] | Common Class A [Member] | ||||
Stockholders' equity | ||||
Common stock | ||||
Adjustments [Member] | Common Class B [Member] | ||||
Stockholders' equity | ||||
Common stock |
SUMMARY OF SIGNIFICANT ACCOUN30
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Balance Sheet) (Details) (Parenthetical) - $ / shares | Mar. 31, 2018 | Dec. 31, 2017 | Mar. 31, 2017 | Dec. 31, 2016 |
Preferred Stock, shares authorized | 50,000,000 | 50,000,000 | 50,000,000 | 50,000,000 |
Preferred Stock, par value per share | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 |
Preferred Stock, shares issued | 0 | 0 | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 | 0 | 0 |
Common Class A [Member] | ||||
Common Stock, shares authorized | 250,000,000 | 250,000,000 | 50,000,000 | 50,000,000 |
Common Stock, par value per share | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 |
Common Stock, shares issued | 10,212,738 | 9,910,565 | 8,025,017 | 6,951,077 |
Common Stock, shares outstanding | 10,212,738 | 9,910,565 | 8,025,017 | 6,951,077 |
Common Class B [Member] | ||||
Common Stock, shares authorized | 9,000,000 | 9,000,000 | 9,000,000 | 9,000,000 |
Common Stock, par value per share | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 |
Common Stock, shares issued | 0 | 0 | 0 | 0 |
Common Stock, shares outstanding | 0 | 0 | 0 | 0 |
SUMMARY OF SIGNIFICANT ACCOUN31
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Income Statements) (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
Revenues | $ 2,110,850 | $ 5,326,163 |
Cost of revenue | 818,105 | 3,279,120 |
Gross profit | 1,292,745 | 2,047,043 |
Operating expense | ||
General, selling and administrative expense | 4,130,258 | 4,409,807 |
Write-off of non-compete agreement | 468,751 | |
Restructuring costs | 377,961 | |
Total operating expense, net | 4,130,258 | 5,256,519 |
Loss from operations | (2,837,513) | (3,209,476) |
Other income (expense) | ||
Interest income (expense) | (434,785) | (133,306) |
Amortization of debt issuance costs | (332,658) | (578,140) |
Total interest expense | (767,443) | (711,446) |
Exchange Gain or Loss | (4,664) | |
Total other income (expense) | (772,107) | (711,446) |
Loss before provision for income taxes | (3,609,620) | (3,920,922) |
Provision for income taxes | ||
Net loss | $ (3,609,620) | $ (3,920,922) |
Net (loss) income per share, basic and diluted | $ (0.36) | $ (0.50) |
Weighted average shares outstanding, basic and diluted | 10,037,905 | 7,844,127 |
As Reported [Member] | ||
Revenues | $ 5,326,163 | |
Cost of revenue | 3,279,120 | |
Gross profit | 2,047,043 | |
Operating expense | ||
General, selling and administrative expense | 4,409,807 | |
Write-off of non-compete agreement | 468,751 | |
Restructuring costs | 377,961 | |
Total operating expense, net | 5,256,519 | |
Loss from operations | (3,209,476) | |
Other income (expense) | ||
Amortization of debt issuance costs | (133,306) | |
Total interest expense | (578,140) | |
Accretion of put warrants | (711,446) | |
Exchange Gain or Loss | 1,894,563 | |
Total other income (expense) | 1,183,117 | |
Loss before provision for income taxes | (2,026,359) | |
Provision for income taxes | ||
Net loss | $ (2,026,359) | |
Net (loss) income per share, basic and diluted | $ (0.26) | |
Weighted average shares outstanding, basic and diluted | 7,844,127 | |
Adjustments [Member] | ||
Revenues | ||
Cost of revenue | ||
Operating expense | ||
General, selling and administrative expense | ||
Write-off of non-compete agreement | ||
Restructuring costs | ||
Total operating expense, net | ||
Loss from operations | ||
Other income (expense) | ||
Interest income (expense) | ||
Amortization of debt issuance costs | ||
Total interest expense | ||
Accretion of put warrants | ||
Exchange Gain or Loss | (1,894,563) | |
Total other income (expense) | (1,894,563) | |
Loss before provision for income taxes | (1,894,563) | |
Provision for income taxes | ||
Net loss | $ (1,894,563) | |
Net (loss) income per share, basic and diluted | $ (0.24) | |
Weighted average shares outstanding, basic and diluted |
SUMMARY OF SIGNIFICANT ACCOUN32
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Cash Flow) (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||
Apr. 30, 2017 | Jan. 31, 2017 | Mar. 31, 2018 | Mar. 31, 2017 | Dec. 31, 2017 | |
Cash flows from operating activities | |||||
Net income (loss) | $ (3,609,620) | $ (3,920,922) | |||
Adjustments to reconcile net loss to net cash used by operating activities: | |||||
Stock based compensation | 166,130 | 512,442 | |||
Amortization of debt issue costs | 93,639 | 578,140 | |||
Accretion of put warrants | |||||
Write-off of non-compete agreement | 468,751 | ||||
Provision for bad debts | (425) | (8,277) | |||
Depreciation expense | 9,441 | 3,234 | |||
Amortization of intangibles | 166,185 | 107,720 | |||
Changes in operating assets and liabilities: | |||||
Accounts receivable | 2,614,671 | 1,840,549 | |||
Prepaid expenses | (72,416) | 2,071 | |||
Other assets | (3,445) | ||||
Accounts payable and accrued expenses | (178,022) | (195,150) | |||
Unearned revenue | |||||
Cash (used) provided by operating activities | (574,844) | (611,442) | |||
Cash flows from investing activities: | |||||
Purchase of equipment | (20,793) | (5,821) | |||
Development of software | (231,774) | (135,241) | |||
Cash used in investing activities | (252,567) | (141,062) | |||
Cash flows from financing activities: | |||||
Proceeds from the issuance of common stock, net | $ 4,566,405 | $ 3,830,000 | 3,820,001 | ||
Repayments of note payable and PIK interest | (3,996,928) | $ (3,996,928) | |||
Net cash provided by financing activities | (176,927) | ||||
Net decrease in cash and cash equivalents | (827,411) | (929,431) | |||
Cash and cash equivalents, beginning of period | 119,331 | 1,048,762 | 1,017,299 | 1,048,762 | 1,048,762 |
Cash and cash equivalents, end of period | 189,888 | 119,331 | 1,017,299 | ||
Supplemental Schedule of Cash Flow Information: | |||||
Cash paid for interest | 340,684 | 550,695 | |||
Cash paid for taxes | |||||
As Reported [Member] | |||||
Cash flows from operating activities | |||||
Net income (loss) | (2,026,359) | ||||
Adjustments to reconcile net loss to net cash used by operating activities: | |||||
Stock based compensation | 512,442 | ||||
Amortization of debt issue costs | 578,140 | ||||
Accretion of put warrants | (1,894,563) | ||||
Write-off of non-compete agreement | 468,751 | ||||
Provision for bad debts | (8,277) | ||||
Depreciation expense | 3,234 | ||||
Amortization of intangibles | 107,720 | ||||
Changes in operating assets and liabilities: | |||||
Accounts receivable | 1,840,549 | ||||
Prepaid expenses | 2,071 | ||||
Other assets | |||||
Accounts payable and accrued expenses | (195,150) | ||||
Unearned revenue | |||||
Cash (used) provided by operating activities | (611,442) | ||||
Cash flows from investing activities: | |||||
Purchase of equipment | (5,821) | ||||
Development of software | (135,241) | ||||
Cash used in investing activities | (141,062) | ||||
Cash flows from financing activities: | |||||
Proceeds from the issuance of common stock, net | 3,820,001 | ||||
Proceeds from notes payable | |||||
Repayments of note payable and PIK interest | (3,996,928) | ||||
Net cash provided by financing activities | (176,927) | ||||
Net decrease in cash and cash equivalents | (929,431) | ||||
Cash and cash equivalents, beginning of period | 119,331 | 1,048,762 | 1,048,762 | 1,048,762 | |
Cash and cash equivalents, end of period | 119,331 | ||||
Supplemental Schedule of Cash Flow Information: | |||||
Cash paid for interest | 550,695 | ||||
Cash paid for taxes | |||||
Adjustments [Member] | |||||
Cash flows from operating activities | |||||
Net income (loss) | (1,894,563) | ||||
Adjustments to reconcile net loss to net cash used by operating activities: | |||||
Stock based compensation | |||||
Amortization of debt issue costs | |||||
Accretion of put warrants | 1,894,563 | ||||
Write-off of non-compete agreement | |||||
Provision for bad debts | |||||
Depreciation expense | |||||
Amortization of intangibles | |||||
Changes in operating assets and liabilities: | |||||
Accounts receivable | |||||
Prepaid expenses | |||||
Other assets | |||||
Accounts payable and accrued expenses | |||||
Unearned revenue | |||||
Cash (used) provided by operating activities | |||||
Cash flows from investing activities: | |||||
Purchase of equipment | |||||
Development of software | |||||
Cash used in investing activities | |||||
Cash flows from financing activities: | |||||
Proceeds from the issuance of common stock, net | |||||
Proceeds from notes payable | |||||
Repayments of note payable and PIK interest | |||||
Net cash provided by financing activities | |||||
Cash and cash equivalents, beginning of period | |||||
Cash and cash equivalents, end of period | |||||
Supplemental Schedule of Cash Flow Information: | |||||
Cash paid for interest | |||||
Cash paid for taxes |
ACQUISITIONS (Details)
ACQUISITIONS (Details) | Oct. 30, 2014 |
Steel Media [Member] | |
Business Acquisition [Line Items] | |
Ownership acquired (as a percent) | 100.00% |
PROPERTY AND EQUIPMENT, NET (Sc
PROPERTY AND EQUIPMENT, NET (Schedule of Property and equipment) (Details) - USD ($) | 3 Months Ended | ||
Mar. 31, 2018 | Mar. 31, 2017 | Dec. 31, 2017 | |
Property, Plant and Equipment [Abstract] | |||
Office equipment | $ 272,207 | $ 251,415 | |
Accumulated depreciation | (106,309) | (96,869) | |
Property and equipment, net | 165,898 | $ 58,079 | $ 154,546 |
Depreciation expense | $ 9,441 | $ 3,234 |
INTANGIBLE ASSETS (Schedule of
INTANGIBLE ASSETS (Schedule of Intangible assets) (Details) - USD ($) | Mar. 31, 2018 | Dec. 31, 2017 | Mar. 31, 2017 |
Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets | $ 3,608,983 | $ 3,377,209 | |
Accumulated amortization | (1,900,634) | (1,734,449) | |
Carrying value | 1,708,349 | 1,642,760 | $ 924,011 |
Non-compete agreement [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets | 1,250,000 | 1,250,000 | |
Intellectual property [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets | 756,000 | 756,000 | |
Acquired software - Leapfrog [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets | 617,069 | 617,069 | |
Internally developed software [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets | $ 985,914 | $ 754,140 |
INTANGIBLE ASSETS (Narrative) (
INTANGIBLE ASSETS (Narrative) (Details) - USD ($) | 1 Months Ended | 3 Months Ended | ||
Aug. 17, 2017 | Mar. 31, 2018 | Mar. 31, 2017 | Oct. 31, 2017 | |
Finite-Lived Intangible Assets [Line Items] | ||||
Capitalization of costs associated with the development of internal use software | $ 231,774 | $ 135,241 | ||
Exercise price of warrants | $ 1.40 | |||
Write-off of non-compete agreement | 468,751 | |||
Remainder of 2018 | 514,592 | |||
2,019 | 662,094 | |||
2,020 | 205,690 | |||
2,021 | 325,973 | |||
Estimated future amortization expense, total | 1,708,349 | |||
Common Class A [Member] | Warrant [Member] | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
Exercise price of warrants | $ 3 | |||
Leapfrog Media Trading [Member] | Warrant [Member] | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
Number of warrants issued | 350,000 | |||
Warrants term | 5 years | |||
Exercise price of warrants | $ 3 | |||
Leapfrog Media Trading [Member] | Common Class A [Member] | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
Number of shares exchanged in asset purchase | 200,000 | |||
Intellectual property [Member] | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
Amortization expense | 37,800 | 37,800 | ||
Non-compete agreement [Member] | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
Write-off of non-compete agreement | 468,750 | |||
Amortization expense | 52,083 | 52,083 | ||
Internally developed software [Member] | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
Amortization expense | $ 76,301 | $ 17,837 |
ACCOUNTS PAYABLE AND ACCRUED 37
ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - USD ($) | Mar. 31, 2018 | Dec. 31, 2017 |
Accounts Payable and Accrued Liabilities [Abstract] | ||
Accounts payable, trade | $ 3,145,279 | $ 2,858,871 |
Accrued expenses | 1,440,440 | 1,800,621 |
Accrued compensation | 94,128 | 256,164 |
Accrued commissions | 2,947 | 95,159 |
Total | $ 4,682,794 | $ 5,010,815 |
NOTES PAYABLE (Financing Agreem
NOTES PAYABLE (Financing Agreement with Victory Park Management, LLC) (Details) - USD ($) | Oct. 30, 2014 | Oct. 27, 2017 | Mar. 31, 2018 | Mar. 31, 2017 | Dec. 31, 2017 | Oct. 31, 2017 |
Debt Instrument [Line Items] | ||||||
Exercise price of warrants | $ 1.40 | |||||
Amortization of debt issue costs | $ 332,658 | $ 578,140 | ||||
Repayments of note payable | $ 3,996,928 | $ 3,996,928 | ||||
Financing Agreement [Member] | Victory Park Management, LLC [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Interest rate (as a percent) | 10.00% | |||||
Paid-in-kind interest rate (as a percent) | 4.00% | |||||
Exercise price of warrants | $ 5 | |||||
Beneficially own shares as a percentage of shares outstanding | 4.99% | |||||
Percentage of revenue used as base to calculate purchase price | 50.00% | |||||
Amount used as base to calculate purchase price | $ 1,500,000 | $ 1,567,612 | ||||
Amortization of debt issue costs | 0 | 578,140 | ||||
Costs related to agreement | $ 3,164,352 | |||||
PIK interest expense accrued to principal | $ 67,612 | $ 0 | $ 0 | |||
Interest rate percentage on unpaid right | 14.00% | |||||
Financing Agreement [Member] | Victory Park Management, LLC [Member] | Common Class A [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Number of shares callable by warrant | 580,000 | |||||
Financing Agreement [Member] | Victory Park Management, LLC [Member] | Maximum [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Paid-in-kind interest rate (as a percent) | 4.00% | |||||
Financing Agreement [Member] | Victory Park Management, LLC [Member] | Minimum [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Paid-in-kind interest rate (as a percent) | 2.00% |
NOTES PAYABLE (Financing Agre39
NOTES PAYABLE (Financing Agreement with Fast Pay Partners, LLC) (Details) - USD ($) | 1 Months Ended | ||
Apr. 30, 2017 | Mar. 31, 2018 | Oct. 31, 2017 | |
Debt Instrument [Line Items] | |||
Notes issued | $ 3,180,158 | ||
Financing Agreement [Member] | Fast Pay Partners, LLC [Member] | |||
Debt Instrument [Line Items] | |||
Notes issued | $ 1,287,176 | ||
Percentage of accounts receivable pledged | 80.00% | ||
Maximum amount of advances pledged | $ 4,000,000 | ||
Concentration limitation on percentage of debt from any single customer | 25.00% | ||
Concentration limitation on percentage of debt from larger customer | 30.00% | ||
Initial term | 18 months |
PUT WARRANT LIABILITY (Narrativ
PUT WARRANT LIABILITY (Narrative) (Details) - USD ($) | Jan. 04, 2017 | Apr. 30, 2017 | Mar. 31, 2018 | Mar. 31, 2017 |
Class of Warrant or Right [Line Items] | ||||
Fair value | $ 1,143,781 | |||
Repurchase of warrant | $ 2,500,000 | |||
Gain on change in fair value of derivative liability | $ 1,894,563 | |||
Loss on repricing of Series A warrants | $ 99,820 | |||
Series A Warrants [Member] | ||||
Class of Warrant or Right [Line Items] | ||||
Rick-free interest rate | 2.00% | 1.875% | ||
Expected term | 5 years 6 months | 5 years 3 months | ||
Expected volatility | 110.00% | 110.00% | ||
Dividend yield | 0.00% | 0.00% | ||
Reset exercise price of Series A Warrants resulting from sale of Debentures | $ 2.245 | |||
Series B Warrants [Member] | ||||
Class of Warrant or Right [Line Items] | ||||
Rick-free interest rate | 2.00% | 1.875% | ||
Expected term | 5 years | 4 years 9 months | ||
Expected volatility | 110.00% | 110.00% | ||
Dividend yield | 0.00% | 0.00% | ||
Repurchase of warrant | $ 2,500,000 |
PUT WARRANT LIABILITY (Details)
PUT WARRANT LIABILITY (Details) | 3 Months Ended |
Mar. 31, 2017USD ($) | |
Initial derivative liability on issuance of put warrants | |
Less accretion of put warrants | |
Put warrant liability | |
As Reported [Member] | |
Initial derivative liability on issuance of put warrants | 3,038,344 |
Less accretion of put warrants | (1,894,563) |
Put warrant liability | 1,143,781 |
Adjustments [Member] | |
Initial derivative liability on issuance of put warrants | (3,038,344) |
Less accretion of put warrants | 1,894,563 |
Put warrant liability | $ (1,143,781) |
SECURED CONVERTIBLE DEBENTURE42
SECURED CONVERTIBLE DEBENTURES, NET (Narrative) (Details) - USD ($) | Jan. 04, 2017 | Dec. 29, 2016 | Oct. 31, 2017 | Oct. 26, 2017 | Apr. 30, 2017 | Jan. 31, 2017 | Mar. 31, 2018 | Mar. 31, 2017 | Jan. 31, 2018 | Dec. 31, 2017 | Dec. 29, 2017 | Dec. 31, 2016 |
Debt Instrument [Line Items] | ||||||||||||
Debenture principal amount | $ 3,180,158 | |||||||||||
Sale of common stock | $ 4,566,405 | $ 3,830,000 | $ 3,820,001 | |||||||||
Exercise price of warrants | $ 1.40 | |||||||||||
Conversion price | $ 1.40 | |||||||||||
Interest expense | 330,952 | |||||||||||
Amortization of debt discount and deferred financing costs | 332,658 | $ 578,140 | ||||||||||
Accrual of partial liquidated damages resulting from noncompliance of filing Registration Statement | $ 103,862 | |||||||||||
Percentage of accrued interest | 18.00% | |||||||||||
Chardan Capital Markets, LLC [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Fee percentage of proceeds | 4.00% | |||||||||||
Series A Warrants [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Stock issued, shares | 183,337 | |||||||||||
Exercise price of warrants | $ 2.245 | $ 1.40 | ||||||||||
Warrant fee percentage | 2.00% | |||||||||||
Threshhold of ownership | 4.99% | |||||||||||
Conversion price | $ 3 | |||||||||||
Series A Warrants [Member] | Maximum [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Threshhold of ownership | 9.99% | |||||||||||
Warrant [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Proceeds used to satisfy put obligation | 2,500,000 | |||||||||||
Warrant [Member] | Chardan Capital Markets, LLC [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Warrants to purchase shares of common stock, number of shares of common stock | 160,000 | |||||||||||
Warrant [Member] | Aspenwood [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Exercise price of warrants | $ 3.75 | |||||||||||
Warrants to purchase shares of common stock, number of shares of common stock | 23,337 | |||||||||||
PA Warrants [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Stock issued, shares | 129,176 | |||||||||||
Exercise price of warrants | $ 3.75 | |||||||||||
Exercise period of warrants | 5 years 6 months | |||||||||||
PA Warrants 1 [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Stock issued, shares | 54,161 | |||||||||||
Exercise price of warrants | $ 4.49 | |||||||||||
Common Class A [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Sale of common stock | $ 3,980,001 | |||||||||||
Stock issued, shares | 761,905 | |||||||||||
Stock issued for reimbursement of expenses, shares | 225,000 | |||||||||||
Threshhold of ownership | 9.99% | |||||||||||
Common Stock, shares authorized | 250,000,000 | 50,000,000 | 250,000,000 | 50,000,000 | ||||||||
Common Class A [Member] | Chardan Capital Markets, LLC [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Exercise price of warrants | $ 6.50 | |||||||||||
Warrants to purchase shares of common stock, number of shares of common stock | 76,190 | |||||||||||
Common Class A [Member] | Series A Warrants [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Exercise price of warrants | $ 6.70 | |||||||||||
Warrants to purchase shares of common stock, number of shares of common stock | 380,953 | |||||||||||
Common Class A [Member] | Series A Warrants [Member] | Minimum [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Exercise price of warrants | $ 1.20 | |||||||||||
Common Class A [Member] | Series B Warrants [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Exercise price of warrants | $ 7 | |||||||||||
Warrants to purchase shares of common stock, number of shares of common stock | 380,953 | |||||||||||
Common Class A [Member] | Series B Warrants [Member] | Minimum [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Exercise price of warrants | $ 1.20 | |||||||||||
Common Class A [Member] | Warrant [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Debenture principal amount | $ 2,000,000 | |||||||||||
Interest rate | 12.50% | |||||||||||
Stock issued, shares | 863,365 | |||||||||||
Exercise price of warrants | $ 3 | |||||||||||
Series A-1 Debentures [Member] | Warrant [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Stock issued, shares | 333,335 | |||||||||||
Series A-2 Debentures [Member] | Warrant [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Stock issued, shares | 530,030 | |||||||||||
Securities Purchase Agreements [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Debenture principal amount | $ 5,180,158 | $ 5,000,000 | ||||||||||
Interest rate | 12.50% | 12.50% | ||||||||||
Stock issued, shares | 8,605,018 | |||||||||||
Stock outstanding, shares | 8,605,018 | |||||||||||
Percentage of conversion shares issuable | 19.99% | |||||||||||
Maturity date | Apr. 21, 2020 | |||||||||||
Interest rate | 0.125 | |||||||||||
Securities Purchase Agreements [Member] | Affiliate of Noble [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Debenture principal amount | $ 720,000 | |||||||||||
Warrants to purchase shares of common stock, number of shares of common stock | 120,000 | |||||||||||
Securities Purchase Agreements [Member] | Three Broker-Dealers [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Placement agent commissions | $ 276,700 | |||||||||||
Securities Purchase Agreements [Member] | Chardan Capital Markets, LLC [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Placement agent commissions - cash | $ 149,021 | |||||||||||
Securities Purchase Agreements [Member] | Aspenwood [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Placement agent commissions - cash | 70,000 | |||||||||||
Securities Purchase Agreements [Member] | Series A Warrants [Member] | Green Shoe [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Debenture principal amount | $ 2,000,000 | |||||||||||
Securities Purchase Agreements [Member] | PA Warrants [Member] | Chardan Capital Markets, LLC [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Stock issued, shares | 160,000 | |||||||||||
Securities Purchase Agreements [Member] | PA Warrants [Member] | Aspenwood [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Stock issued, shares | 23,337 | |||||||||||
Securities Purchase Agreements [Member] | Common Class A [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Threshhold of ownership | 20.00% | |||||||||||
Securities Purchase Agreements [Member] | Common Class A [Member] | Colorado Financial Service Corporation [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Exercise price of warrants | $ 3.75 | |||||||||||
Warrants to purchase shares of common stock, number of shares of common stock | 7,700 | |||||||||||
Exercise period of warrants | 5 years 6 months | |||||||||||
Securities Purchase Agreements [Member] | Common Class A [Member] | Noble Capital Markets [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Exercise price of warrants | $ 3 | |||||||||||
Warrants to purchase shares of common stock, number of shares of common stock | 66,800 | |||||||||||
Exercise period of warrants | 6 months | |||||||||||
Securities Purchase Agreements [Member] | Common Class A [Member] | Chardan Capital Markets, LLC [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Exercise price of warrants | $ 3.75 | |||||||||||
Warrants to purchase shares of common stock, number of shares of common stock | 100,000 | |||||||||||
Exercise period of warrants | 5 years 6 months | |||||||||||
Securities Purchase Agreements [Member] | Common Class A [Member] | Series A Warrants [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Exercise price of warrants | $ 3 | $ 3 | ||||||||||
Warrants to purchase shares of common stock, number of shares of common stock | 863,365 | 833,337 | ||||||||||
Exercise period of warrants | 5 years | 3 years | ||||||||||
Premium exercise percentage during first year | 120.00% | |||||||||||
Premium exercise percentage during the remainder of the term | 120.00% | 110.00% | ||||||||||
Threshhold of ownership | 110.00% | 4.99% | ||||||||||
Securities Purchase Agreements [Member] | Common Class A [Member] | Series A Warrants [Member] | Minimum [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Exercise price of warrants | $ 1.40 | |||||||||||
Securities Purchase Agreements [Member] | Common Class A [Member] | Series A Warrants [Member] | Maximum [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Threshhold of ownership | 9.99% | |||||||||||
Securities Purchase Agreements [Member] | Common Class A [Member] | Series B Warrants [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Percentage of conversion shares issuable | 50.00% | |||||||||||
Fee percentage of proceeds | 50.00% | 20.00% | ||||||||||
Voting agreement percentage of shareholders | 20.00% | |||||||||||
Securities Purchase Agreements [Member] | Series A-1 Debentures [Member] | Series A Warrants [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Debenture principal amount | $ 2,000,000 | |||||||||||
Conversion price | $ 1.40 | |||||||||||
Securities Purchase Agreements [Member] | Series A-2 Debentures [Member] | Series A Warrants [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Debenture principal amount | $ 3,180,158 | |||||||||||
Conversion price | $ 3 | $ 1.40 | ||||||||||
Securities Purchase Agreements, Additional Debentures [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Debenture principal amount | $ 3,180,158 | $ 3,000,000 | ||||||||||
Common Stock, shares authorized | 1,720,143 | |||||||||||
Convertible Notes [Member] | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Debenture principal amount | $ 3,335,000 | |||||||||||
Stock issued, shares | 1,111,667 |
SECURED CONVERTIBLE DEBENTURE43
SECURED CONVERTIBLE DEBENTURES, NET (Schedule of Secured Convertible Notes) (Details) - USD ($) | Mar. 31, 2018 | Dec. 31, 2017 |
Convertible Debt [Abstract] | ||
2,018 | ||
2,019 | ||
2,020 | 6,845,157 | |
Total minimum principal payments | 6,845,157 | |
Less: debt discount and deferred debt issuance costs | (4,801,353) | |
Convertible notes, net | $ 2,043,804 | $ 1,711,146 |
STOCKHOLDERS' EQUITY (Preferred
STOCKHOLDERS' EQUITY (Preferred and Common Stock) (Details) - USD ($) | Jan. 04, 2017 | Jan. 04, 2017 | Jan. 02, 2017 | Dec. 29, 2016 | Mar. 31, 2018 | Jan. 31, 2018 | Oct. 31, 2017 | Oct. 26, 2017 | Oct. 17, 2017 | Sep. 15, 2017 | Aug. 17, 2017 | Apr. 30, 2017 | Mar. 31, 2017 | Feb. 28, 2017 | Jan. 31, 2017 | Nov. 30, 2016 | Mar. 31, 2018 | Mar. 31, 2017 | Jan. 31, 2018 | Sep. 30, 2017 | Jan. 24, 2018 |
Class of Stock [Line Items] | |||||||||||||||||||||
Proceeds from the sale of stock | $ 4,566,405 | $ 3,830,000 | $ 3,820,001 | ||||||||||||||||||
Proceeds from the sale of stock | $ 630,030 | ||||||||||||||||||||
Exercise price of warrants | $ 1.40 | ||||||||||||||||||||
Share price | $ 3 | ||||||||||||||||||||
Stock based compensation | 166,130 | 512,442 | |||||||||||||||||||
Stock award expenses | 52,189 | 144,848 | |||||||||||||||||||
Repurchase of warrant | 2,500,000 | ||||||||||||||||||||
Debenture principal amount | $ 3,180,158 | ||||||||||||||||||||
Conversion price | $ 1.40 | ||||||||||||||||||||
Warrant [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Proceeds from the sale of stock | $ 333,335 | ||||||||||||||||||||
Warrant [Member] | Leapfrog Media Trading [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Exercise price of warrants | $ 3 | ||||||||||||||||||||
Series B Warrants [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Repurchase of warrant | $ 2,500,000 | ||||||||||||||||||||
Series A Warrants [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Stock issued, shares | 183,337 | ||||||||||||||||||||
Exercise price of warrants | $ 2.245 | $ 2.245 | $ 1.40 | ||||||||||||||||||
Threshhold of ownership | 4.99% | ||||||||||||||||||||
Conversion price | $ 3 | ||||||||||||||||||||
Series A Warrants [Member] | Maximum [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Threshhold of ownership | 9.99% | ||||||||||||||||||||
Stock Option [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Stock based compensation | $ 83,941 | $ 33,419 | |||||||||||||||||||
Al & J Media [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Stock issued for services, shares | 150,000 | ||||||||||||||||||||
Chardan Capital Markets, LLC [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Cash fee amount | $ 160,000 | ||||||||||||||||||||
Fee percentage of proceeds | 4.00% | ||||||||||||||||||||
Reimbursement amount | $ 15,000 | ||||||||||||||||||||
Chardan Capital Markets, LLC [Member] | Warrant One [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Number of shares callable by warrants | 129,176 | ||||||||||||||||||||
Exercise price of warrants | $ 3.75 | ||||||||||||||||||||
Chardan Capital Markets, LLC [Member] | Warrant Two [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Number of shares callable by warrants | 54,161 | ||||||||||||||||||||
Exercise price of warrants | $ 4.49 | ||||||||||||||||||||
Chardan Capital Markets, LLC [Member] | Warrant [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Number of shares callable by warrants | 160,000 | ||||||||||||||||||||
Award term | 5 years 6 months | ||||||||||||||||||||
Aspenwood Capital [Member] | Warrant [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Number of shares callable by warrants | 23,337 | ||||||||||||||||||||
Exercise price of warrants | $ 3.75 | ||||||||||||||||||||
Common Class A [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Proceeds from the sale of stock | $ 3,980,001 | ||||||||||||||||||||
Stock issued, shares | 761,905 | ||||||||||||||||||||
Threshhold of ownership | 9.99% | ||||||||||||||||||||
Stock issued for services, value | $ 1,137,650 | ||||||||||||||||||||
Stock issued for services, shares | 225,000 | ||||||||||||||||||||
Shares issued for stock awards that have vested | 51,667 | ||||||||||||||||||||
Debt conversion shares issued | 218,334 | ||||||||||||||||||||
Debt conversion converted amount | $ 655,000 | ||||||||||||||||||||
Common Class A [Member] | Leapfrog Media Trading [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Number of shares exchanged in asset purchase | 200,000 | ||||||||||||||||||||
Common Class A [Member] | Minimum [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Share price | $ 10 | $ 10 | |||||||||||||||||||
Common Class A [Member] | Warrant [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Stock issued, shares | 863,365 | ||||||||||||||||||||
Proceeds from the sale of stock | $ 5,180,158 | ||||||||||||||||||||
Exercise price of warrants | $ 3 | ||||||||||||||||||||
Interest rate | 12.50% | ||||||||||||||||||||
Maturity Date | Apr. 21, 2020 | ||||||||||||||||||||
Debenture principal amount | $ 2,000,000 | ||||||||||||||||||||
Common Class A [Member] | Series B Warrants [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Number of shares callable by warrants | 380,953 | 380,953 | |||||||||||||||||||
Exercise price of warrants | $ 7 | $ 7 | |||||||||||||||||||
Award term | 5 years | ||||||||||||||||||||
Repurchase of warrant | $ 2,500,000 | ||||||||||||||||||||
Common Class A [Member] | Series B Warrants [Member] | Minimum [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Exercise price of warrants | $ 1.20 | $ 1.20 | |||||||||||||||||||
Share price | $ 5.25 | $ 5.25 | |||||||||||||||||||
Common Class A [Member] | Series B Warrants [Member] | Maximum [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Cashless payment amount | $ 2,500,000 | $ 2,500,000 | |||||||||||||||||||
Common Class A [Member] | Series A Warrants [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Number of shares callable by warrants | 380,953 | 380,953 | |||||||||||||||||||
Exercise price of warrants | $ 6.70 | $ 6.70 | |||||||||||||||||||
Common Class A [Member] | Series A Warrants [Member] | Minimum [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Exercise price of warrants | $ 1.20 | $ 1.20 | |||||||||||||||||||
Common Class A [Member] | Chardan Capital Markets, LLC [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Number of shares callable by warrants | 76,190 | ||||||||||||||||||||
Exercise price of warrants | $ 6.50 | ||||||||||||||||||||
Award term | 5 years 6 months | ||||||||||||||||||||
Common Class A [Member] | Al & J Media, Inc [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Stock issued for services, value | $ 97,500 | ||||||||||||||||||||
Stock issued for services, shares | 75,000 | ||||||||||||||||||||
Common Class A [Member] | Kathy Ireland Worldwide LLC [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Stock issued for services, value | $ 678,000 | ||||||||||||||||||||
Stock issued for services, shares | 100,000 | ||||||||||||||||||||
Common Class A [Member] | Mr. Derek J. Ferguson [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Stock issued for services, value | $ 12,500 | ||||||||||||||||||||
Stock issued for services, shares | 3,858 | ||||||||||||||||||||
Common Class A [Member] | Mr. Steven Antebi [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Number of shares callable by warrants | 200,000 | ||||||||||||||||||||
Stock issued for services, value | $ 540,000 | ||||||||||||||||||||
Stock issued for services, shares | 150,000 | ||||||||||||||||||||
Common Class A [Member] | Mr. Robert Jordan [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Stock issued for services, value | $ 12,500 | ||||||||||||||||||||
Stock issued for services, shares | 6,510 | ||||||||||||||||||||
Common Class A [Member] | Consultant [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Number of shares callable by warrants | 200,000 | ||||||||||||||||||||
Common Class A [Member] | Market Street Investor Relations, LLC [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Number of shares callable by warrants | 400,000 | ||||||||||||||||||||
Warrants outstanding | 1,390,264 | ||||||||||||||||||||
Exercise price of warrants | $ 7.50 | ||||||||||||||||||||
Placement agent fees | $ 100,000 | $ 50,000 | |||||||||||||||||||
Stock based compensation | $ 275,637 | ||||||||||||||||||||
Common Class A [Member] | Employee [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Stock issued, shares | 6,667 | ||||||||||||||||||||
Common Class A [Member] | Employee [Member] | Compensation 2016 Plan [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Stock issued, shares | 122,950 | ||||||||||||||||||||
Common Class A [Member] | Colleen DiClaudio [Member] | Compensation 2016 Plan [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Stock issued for services, value | $ 10,000 | ||||||||||||||||||||
Stock issued for services, shares | 7,813 | ||||||||||||||||||||
Common Class A [Member] | Hardy Thomas [Member] | Compensation 2016 Plan [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Stock issued for services, value | $ 10,000 | ||||||||||||||||||||
Stock issued for services, shares | 7,195 | ||||||||||||||||||||
Common Class A [Member] | William Packer [Member] | Compensation 2016 Plan [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Stock issued for services, value | $ 10,000 | ||||||||||||||||||||
Stock issued for services, shares | 3,774 | ||||||||||||||||||||
Common Class A [Member] | Marc Savas and Malcolm CasSelle [Member] | Compensation 2016 Plan [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Stock issued for services, value | $ 10,000 | ||||||||||||||||||||
Stock issued for services, shares | 3,774 | ||||||||||||||||||||
Common Class A [Member] | Chief Financial Officer [Member] | Compensation 2016 Plan [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Stock based compensation, shares | 70,409 | ||||||||||||||||||||
Series A common stock purchase warrants [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Exercise price of warrants | $ 3 | ||||||||||||||||||||
Debenture financing exercised | 83,334 | ||||||||||||||||||||
Proceeds from warrants exercise | $ 250,002 | ||||||||||||||||||||
Common stock purchase warrants [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Warrants outstanding | 662,773 | 662,773 | 176,400 | ||||||||||||||||||
Exercise price of warrants | $ 7.50 | ||||||||||||||||||||
Common stock purchase warrants [Member] | Minimum [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Exercise price of warrants | $ 5 | $ 5 | |||||||||||||||||||
Common stock purchase warrants [Member] | Maximum [Member] | |||||||||||||||||||||
Class of Stock [Line Items] | |||||||||||||||||||||
Exercise price of warrants | $ 10 | $ 10 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details) - USD ($) | Apr. 02, 2018 | Mar. 20, 2018 |
Ms, DeRuggiero, Chief Innovations Officer [Member] | ||
Related Party Transaction [Line Items] | ||
Class A common shares company has right to repurchase from related party per terms of consulting agreement | 514,667 | |
Purchase price per share of Class A common shares company has right to repurchase from related party per terms of consulting agreement | $ 5.80 | |
Aggregate value of Class A common shares company has right to repurchase from related party per terms of consulting agreement | $ 2,985,069 | |
Kristoffer Nelson, Chief Operating Officer [Member] | Common Stock Purchase Warrant [Member] | Subsequent Event [Member] | ||
Related Party Transaction [Line Items] | ||
Options granted | 100,000 | |
Price per share | $ 5.78 | |
Vesting term | 3 years | |
Expected term | 3 years |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2018 | Mar. 31, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | ||
Lease expiration period | Jan. 31, 2018 | |
Rent expense | $ 68,070 | $ 40,212 |
Future minimum lease payments, 2018 | $ 50,636 |
FAIR VALUE OF FINANCIAL INSTR47
FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis) (Details) - USD ($) $ in Thousands | Mar. 31, 2018 | Dec. 31, 2017 |
Warrant put option liability | $ 2,500 | |
Fair value of convertible notes | $ 6,845,257 | 6,845,257 |
Fair Value, Measurements, Recurring [Member] | ||
Total liabilities | ||
Total assets | 189,888 | 1,017,299 |
Fair Value, Measurements, Recurring [Member] | Put Warrant Liability [Member] | ||
Total liabilities | ||
Fair Value, Measurements, Recurring [Member] | Embedded Warrant Put Option [Member] | ||
Total liabilities | ||
Fair Value, Measurements, Recurring [Member] | Embedded Derivatives [Member] | ||
Total liabilities | ||
Fair Value, Measurements, Recurring [Member] | Contingent Consideration [Member] | ||
Total liabilities | ||
Fair Value, Measurements, Recurring [Member] | Certificates of Deposit [Member] | ||
Total assets | ||
Fair Value, Measurements, Recurring [Member] | Money Market Funds [Member] | ||
Total assets | 189,888 | 1,017,299 |
Fair Value, Measurements, Recurring [Member] | US Government Agencies Debt Securities [Member] | ||
Total assets | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | ||
Total liabilities | ||
Total assets | 189,888 | 1,017,299 |
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Put Warrant Liability [Member] | ||
Total liabilities | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Embedded Warrant Put Option [Member] | ||
Total liabilities | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Embedded Derivatives [Member] | ||
Total liabilities | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Contingent Consideration [Member] | ||
Total liabilities | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Certificates of Deposit [Member] | ||
Total assets | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Money Market Funds [Member] | ||
Total assets | 189,888 | 1,017,299 |
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | US Government Agencies Debt Securities [Member] | ||
Total assets | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | ||
Total liabilities | ||
Total assets | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Put Warrant Liability [Member] | ||
Total liabilities | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Embedded Warrant Put Option [Member] | ||
Total liabilities | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Embedded Derivatives [Member] | ||
Total liabilities | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Contingent Consideration [Member] | ||
Total liabilities | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Certificates of Deposit [Member] | ||
Total assets | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Money Market Funds [Member] | ||
Total assets | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | US Government Agencies Debt Securities [Member] | ||
Total assets | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | ||
Total liabilities | ||
Total assets | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Put Warrant Liability [Member] | ||
Total liabilities | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Embedded Warrant Put Option [Member] | ||
Total liabilities | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Embedded Derivatives [Member] | ||
Total liabilities | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Contingent Consideration [Member] | ||
Total liabilities | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Certificates of Deposit [Member] | ||
Total assets | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Money Market Funds [Member] | ||
Total assets | ||
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | US Government Agencies Debt Securities [Member] | ||
Total assets |
FAIR VALUE OF FINANCIAL INSTR48
FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Derivative and Warrant Liability Measured on Recurring Basis) (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2018 | Dec. 31, 2017 | |
Fair Value Disclosures [Abstract] | ||
Balance as of beginning of period | $ 1,500 | $ 1,500 |
Payments | ||
Adjustment to fair value | ||
Balance as of end of period | $ 1,500 |